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ABSTRACT 
The Dynamics of Serotonin Receptor Expression in the Developing Forebrain 
 
by 
 
Angela Chen 
 
Serotonin (5-hydroxytryptamine, 5-HT) serves an important modulatory role in 
the entire central nervous system (CNS), and serotonergic abnormalities have been 
implicated in many mental disorders. All of the CNS supply of 5-HT originates in the 
brainstem raphe nuclei. The midbrain dorsal raphe nucleus (DRN) sends widespread 
projections to the forebrain but receives direct input from only a small number of 
forebrain regions, including the medial prefrontal cortex (mPFC). We hypothesized 
that prenatal perturbations of 5-HT levels may alter the forebrain expression of 5-HT 
receptors (5-HTRs) in a time-sensitive manner and that these changes may result in 
persistent changes of the forebrain control of the DRN. Specifically, this thesis 
investigated the susceptibility of 5-HTR expression in the embryonic mouse 
telencephalon to chronic and acute perturbations of 5-HT levels and examined the 
effects of altered 5-HT4R expression on the synaptic structure of the mPFC-DRN 
projection. These studies demonstrated (i) that acute and chronic perturbations of 5-
HT levels affect the expression of 5-HT1AR, 5-HT2AR, and 5-HT4R in the embryonic 
 vii 
 
forebrain and (ii) that altered 5-HT4R expression affects the development of the 
synaptic connectivity between mPFC terminals and DRN serotonergic neurons. These 
findings suggest that prenatal serotonergic perturbations can strongly influence the 
development of the prefrontal control of 5-HT signaling and have long-term 
consequences for behavioral responses later in life. 
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Chapter 1 
General Introduction 
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The Brain 5-HT System 
The 5-HT (serotonin, 5-hydroxytryptamine) system is one of the most widely-
distributed neurotransmitter systems in the central nervous system (CNS). 5-HT is 
synthesized by neurons in the brainstem raphe nuclei (RN), transported by long-
distance axonal projections, and released diffusely or via specific synaptic contacts in 
virtually all CNS regions (Azmitia & Whitaker-Azmitia, 1991; Parnavelas & 
Papadopoulos, 1989). Given the widespread presence of serotonergic axons, it is not 
surprising that 5-HT has been found to play important roles in diverse brain functions, 
including the regulation of emotional states, sleep, and motivation (Fidalgo, Ivanov, 
& Wood, 2013; Olivier, 2004). The forebrain, including the prefrontal cortex (PFC), 
receives a robust serotonergic innervation (Fuxe, 1965; Jacobs & Azmitia, 1992; 
Lidov, Grzanna, & Molliver, 1980), which modulates various cognitive functions, 
such as learning, memory, categorization, inhibitory control, and cognitive flexibility.  
The biosynthesis of 5-HT begins with an essential amino acid, L-tryptophan. 
Tryptophan is first hydroxylated into 5-hydroxytryptophan (5-HTP) by the rate-
limiting enzyme tryptophan hydroxylase (TPH), which is found only in 5-HT-
synthesizing cells. Two isoforms of TPH, TPH1 and TPH2, have been identified. 
TPH1 is expressed primarily by the gut enterochomaffin cells and in the placenta 
(Bonnin et al., 2011), while TPH2 is expressed almost exclusively by neurons in the 
central and enteric nervous systems (P. D. Patel, Pontrello, & Burke, 2004; Walther et 
al., 2003). Animals lacking a functional TPH1 maintain normal 5-HT levels in the 
brain, but exhibit greater than a 90% reduction of 5-HT in the blood and in the 
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gastrointestinal tract (Côté et al., 2003; Savelieva et al., 2008). In contrast, the blood 
and gut 5-HT levels are unaffected in mice lacking a functional TPH2, but more than 
95% of 5-HT in the brain is depleted (Savelieva et al., 2008). Pharmacological agents 
that inhibit TPH (e.g., pCPA) can deplete 5-HT by blocking the hydroxylation step 
and are often used in experimental research. The TPH-mediated step is then followed 
by decarboxylation of 5-HTP into 5-HT by the enzyme aromatic L-amino acid 
decarboxylase (AADC). 5-HT is eventually metabolized by the enzyme monoamine 
oxidase A (MAOA) and aldehyde dehydrogenase (ALDH) into 5-
hydroxyindoleacetic acid (5-HIAA). The level of 5-HIAA in the brain is often 
measured to assess the rate of 5-HT turnover, which may be altered in some brain 
abnormalities. In human studies, the level of 5-HIAA in the cerebrospinal fluid (CSF) 
is often used as an indirect measure of brain 5-HT levels (Wester et al., 1990).  
Altered 5-HT synthesis or release have been implicated in many psychiatric 
disorders, including major depressive disorder (aan het Rot, Mathew, & Charney, 
2009; Carr & Lucki, 2011; Duman, 2007; Jans, Riedel, Markus, & Blokland, 2007; 
Millan, 2004; Tamburella, Micale, Navarria, & Drago, 2009; Wong, Perry, & 
Bymaster, 2005), generalized anxiety disorder (Booij et al., 2010; Lowry et al., 2008; 
Lowry, Johnson, Hay-Schmidt, Mikkelsen, & Shekhar, 2005), schizophrenia 
(Fribourg et al., 2011; González-Maeso & Sealfon, 2009; González-Maeso et al., 
2008; Williams, Rao, & Goldman-Rakic, 2002), and autism-spectrum disorders 
(ASDs) (Azmitia, Singh, & Whitaker-Azmitia, 2011; Chandana et al., 2005; Chugani, 
2002, 2004; Whitaker-Azmitia, 2001). One post-mortem depression study has found 
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decreased brainstem 5-HT levels in suicide victims (SHAW, ECCLESTON, & 
CAMPS, 1967) and various others have reported robust correlations between low 
CSF 5-HIAA and suicidality, aggression, and impulsivity (Asberg, Thorén, Träskman, 
Bertilsson, & Ringberger, 1976; Å sberg, 1997; G. L. Brown et al., 1982). Importantly, 
many pharmaceutical agents targeting the 5-HT system, such as the selective 
serotonin reuptake inhibitors (SSRIs), have been shown to have antidepressant (Blier 
& De Montigny, 1999; Vaswani, Linda, & Ramesh, 2003), anxiolytic (Feighner & 
Boyer, 1989; Menard & Treit, 1999; Vaswani et al., 2003), and/or antipsychotic 
(Meltzer, 2012) properties, and have become a popular choice in pharmaceutical 
treatments of many neurobiological disorders.  
The 5-HT Receptors 
To date, fourteen subtypes of mammalian 5-HT receptors (5-HTRs), divided into 
7 families, have been identified (Barnes & Neumaier, 2011). Some 5-HTRs, 
including 5-HT4R, can be alternatively spliced into multiple functional isoforms 
(Bockaert, Claeysen, Bécamel, Dumuis, & Marin, 2006). These splice variants differ 
in their C-terminal domains that can recruit and interact with specific intracellular 
proteins, leading to finely regulated signal transduction (Bockaert et al., 2006). All 5-
HTRs are G protein-coupled receptors (GPCRs) except for 5-HT3R, which is a 
ligand-gated ion channel. The 5-HT GPCRs consist of 7 transmembrane domains 
with a ligand binding site on the N-terminus and a G-protein association site on the C 
terminus. 5-HT GPCRs are coupled to three types of G-proteins, Gs, Gi, and Gq. 
Upon ligand binding, the receptor changes its conformation and activates the 
 5 
 
associated G-proteins, which detach from the C-terminus and activate various 
intracellular pathways. Downstream changes inside the neuron are induced via the 
activation of second messengers that can affect several cellular processes, including 
membrane ion exchange and gene transcription.  
Since serotonergic axons are widely distributed throughout the CNS, 5-HTRs 
have been identified in most forebrain regions, including the PFC, basal ganglia, 
amygdala, and hippocampus (Beaudoin-Gobert & Sgambato-Faure, 2014). The 5-
HTR family is larger than the GPCR receptor families of other neurotransmitters, 
including dopamine, norepinephrine, glutamate, and acetylcholine (Nichols & 
Nichols, 2008), suggesting a great functional versatility of 5-HT signaling. The 
regional distributions of 5-HTRs are subtype-specific. For example, 5-HT1ARs are 
highly expressed in the dorsal RN (DRN), where the expression of 5-HT2ARs and 5-
HT4Rs is low (Beaudoin-Gobert & Sgambato-Faure, 2014; Lucas et al., 2005).  
Because 5-HT1AR activation leads to neuronal hyperpolarization and a reduced firing 
rate, DRN 5-HT1ARs play a regulatory role in the 5-HT synthesis and release. 5-
HT1ARs are also expressed densely in the limbic system and in layers II and VI of the 
frontal cortex (Pazos & Palacios, 1985). 5-HT2ARs are highly expressed in layers III 
and V of several cortical areas in the human brain (Pazos, Probst, & Palacios, 1987). 
A high-resolution localization study of 5-HT2AR in the primate cerebral cortex has 
shown that 5-HT2ARs are expressed on virtually all pyramidal cells, especially on 
their apical dendrites (Jakab & Goldman-Rakic, 1998). In the brain, 5-HT4Rs are 
densely expressed in the basal ganglia, cortex, hippocampus, and substantia nigra 
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(Bonaventure et al., 2000; Eglen, Wong, Dumuis, & Bockaert, 1995). Because 5-
HT4R is Gs-protein-coupled and densely expressed in the hippocampus, many studies 
have examined its role in long-term potentiation (LTP) and synaptic plasticity (Kemp 
& Manahan-Vaughan, 2005; Kulla & Manahan-Vaughan, 2002; Wawra, Fidzinski, 
Heinemann, Mody, & Behr, 2014). Importantly, studies using 5-HT4R knockout mice 
indicate that 5-HT4Rs modulate 5-HT content in the rostral RNs; specifically, 
decreased 5-HT neuron activity and 5-HT content have been reported in 5-HT4R 
knockout mice (Conductier et al., 2006). This is consistent with the finding that 
systemic injection of a 5-HT4R agonist increases the firing rate of serotonergic DRN 
neurons (Lucas & Debonnel, 2002). Since 5-HT4R is not expressed in the DRN, the 
modulating neurons are likely to be located in the mPFC that projects to the DRN 
(Conductier et al., 2006).  
With at least nine splice variants in humans and four splice variants in mice, 5-
HT4R has the most complex genetic structure of all 5-HTRs (Bockaert, Claeysen, 
Compan, & Dumuis, 2004; Claeysen, Sebben, Becamel, Bockaert, & Dumuis, 1999). 
The four splice variants of 5-HT4R in mice exhibit differences in their C-termini: The 
5-HT4(a)R and 5-HT4(b)R have longer intracellular C-terminal ends and the 5-HT4(e)R 
and 5-HT4(f)R have shorter intracellular C-terminal ends (Claeysen et al., 1999). An 
important difference between the 5-HT4R splice variants is their varying levels of 
constitutive activity. The constitutive activity of a receptor is the ability of a receptor 
to convert from an inactive conformation to an active one without the stimulation of a 
ligand. In the case of 5-HT4R, the basal constitutive activity is measured by the 
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production of cAMP in the absence of a 5-HT4R agonist. An in vitro study has shown 
that all 5-HT4R splice variants are constitutively active, with the 5-HT4(e)R and 5-
HT4(f)R splice variants having a 2-fold higher constitutive activity than the 5-HT4(a)R 
and 5-HT4(b)R splice variants (Claeysen et al., 1999). This splice-variant specific 
difference in activity is likely due to the lengths of the C-termini, since the shortest 
splice variants have a greater ability to isomerize to an active state without ligand-
binding. This is supported by the finding that progressive deletions of the C-terminal 
part of 5-HT4(a)R result in a corresponding increase in constitutive activity (Claeysen 
et al., 1999). 
Aside from the difference in constitutive activity, the 5-HT4R splice variants also 
differ in their internalization patterns. When stimulated with 5-HT, 5-HT4(b)R 
internalizes more efficiently than 5-HT4(a)R (Mnie-Filali et al., 2010). Upon 
endocytosis, 5-HT4(a)Rs stay associated with β-arrestin, a protein that mediates 
internalization and post-endocytic trafficking of GPCRs, and accumulate around the 
perinuclear region (Mnie-Filali et al., 2010). In contrast, 5-HT4(b)Rs dissociate from 
β-arrestin rapidly, recycle back to the cellular membrane, and become functional 
again (Mnie-Filali et al., 2010). The pattern of internalization and subsequent 
recycling has major implications at the transcriptional level because the splice variant 
that recycles to the membrane most efficiently is likely to require less receptor 
synthesis following ligand-induced internalization. Additionally, highly spontaneous, 
ligand-independent internalization of 5-HT4R has been reported, and this constitutive 
internalization is more prominent in 5-HT4(a)R than in 5-HT4(b)R in cultured cortical 
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cells (Mnie-Filali et al., 2010). Lastly, RS67333, a 5-HT4R partial agonist that is 
currently being investigated as a potential rapid-acting antidepressant (Lucas et al., 
2007), produces less 5-HT4R internalization than 5-HT but follows a similar pattern 
of internalization across the 5-HT4R splice variants, as compared to 5-HT (Mnie-
Filali et al., 2010).  
We have previously demonstrated in our laboratory that 5-HT4Rs show an 
mRNA splice variant-specific developmental expression in the mouse telencephalon 
(Hernandez & Janušonis, 2010). As shown in Figure 1.1, the mRNA levels of 5-
HT4(a)R are rapidly upregulated at two developmental times: between E14 and E15 
and between E16 and E17. The mRNA levels of 5-HT4(b)R are rapidly upregulated 
only once, between E14 and E15. The mRNA levels of 5-HT4(e)R and 5-HT4(f)R show 
an almost linear increase between E14 and E17. These upregulation patterns suggest 
that 5-HT4Rs may control developmental processes in a time-sensitive manner.  
Due to the many 5-HT4R splice variant-specific differences and the involvement 
of 5-HT4R in major brain disorders, such as depression and Alzheimer’s disease, the 
characterization and developmental profiling of the 5-HT4R splice variants are 
important for translational research. Because of these considerations, the 5-HT4R 
splice variants were examined separately in this thesis. 
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Figure 1.1. Quantitative RT-PCR (RT-qPCR) analysis has shown that 
the 5-HT4R splice variants have distinct temporal patterns of expression 
in the mouse embryonic telencephalon. The dashed lines indicate all 
significant post-hoc (Tukey HSD) differences between consecutive time 
points. Error bars = SEM. *p<.05, **p<.01 (Hernandez & Janušonis, 
2010). 
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5-HT Interactions with Other Neurotransmitters 
Depending on the associated G-protein and the synaptic location, the 
metabotropic 5-HTRs can act as neurotransmitter release-inhibitors or -facilitators. 
For example, 5-HT1BRs can modulate the presynaptic or postsynaptic release of other 
neurotransmitters, such as acetylcholine, glutamate, dopamine, and norepinephrine 
(Pytliak, Vargová, Mechírová, & Felšöci, 2011). 5-HT4Rs are found on cholinergic 
axon terminals in the hippocampus and can facilitate the release of acetylcholine in 
this region (Fink & Göthert, 2007). In addition, some 5-HT1ARs and 5-HT2A/2CRs are 
expressed on local GABAergic interneurons in brain regions such as the PFC, which 
can inhibit neurotransmitter release from projection neurons (J. De Almeida & 
Mengod, 2007; Julián De Almeida & Mengod, 2008). Because one neurotransmitter 
system can easily regulate another, this type of cross-talk between multiple 
neurotransmitter systems introduces further complexity in the study of the 5-HT 
system.  
Another, less explored mechanism of cross-talk between various 
neurotransmitter systems is the formation of receptor heterodimers. It has been 
demonstrated that many GPCRs, including metabotropic 5-HTRs, can form homo- 
and hetero-dimers. Dimerized receptors become a single signaling unit that can 
exhibit a complex pharmacological dynamic. For example, it has been shown that 5-
HT2AR and the dopamine receptor 2 (D2R) can form a heterodimer, and that specific 
5-HT2AR or D2R ligands can change the recognition and signaling at the other 
receptor (Borroto-Escuela et al., 2010; Lukasiewicz et al., 2010). Specifically, 
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Borroto-Escuela et al. (2010) has shown that 5-HT stimulation of the heterodimer 
leads to inhibition of D2R function, suggesting a 5-HT2AR-mediated D2R trans-
inhibition phenomenon. Also, it has been demonstrated with immunofluorescence 
double-labeling techniques that the two receptors colocalize in the medial PFC 
(mPFC) (Lukasiewicz et al., 2010), one of the few brain regions that directly project 
to the DRN.  
The human 5-HT4R has been reported to homodimerize, as well as 
heterodimerize, with the β2 adrenergic receptor (β2-AR) (Berthouze et al., 2005). 
Therefore, 5-HT4Rs and β2-ARs are well-positioned to integrate serotonergic and 
noradrenergic signals at the single-neuron level. Additionally, the β2-AR gene is 
nested within an untranslated intron of the 5-HT4R gene (Htr4) (Bockaert et al., 2004). 
It should be noted that, in the mammalian genome, it is rare for two proteins with 
similar functions to have a nested gene relationship (Jaworski, Beem-Miller, Lluri, & 
Barrantes-Reynolds, 2007). As a single heterocomplex signaling unit, the two 
receptors may affect each other’s internalization and recycling. For these reasons, 
transcriptional interactions between 5-HT4R and β2-AR were investigated in this 
thesis.  
The Role of 5-HT in Brain Development 
Many lines of research show that long before 5-HT assumes its role as a 
neurotransmitter in the mature brain, it regulates brain development. The 5-HT 
system is one of the first neurotransmitter systems to develop during embryonic 
development. Neurons immunopositive for 5-HT can be detected as early as 
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embryonic day (E) 10-12 in the mouse brain (Pattyn et al., 2004), not long after the 
RN neurons begin to differentiate (Sundström et al., 1993). The axons of the 
serotonergic neurons in the RN then extend rapidly, reaching toward both the 
hindbrain and forebrain. It has been reported that 5-HT expression in development, 
occurs prior to synaptic neurotransmission or synaptogenesis (Bonnin, Peng, Hewlett, 
& Levitt, 2006), indicating that 5-HT can act as an important signal for immature 
brain cells. Studies have implicated 5-HT in various developmental processes, 
including cell proliferation and differentiation. Lauder et al. (1978) has shown that 
maternal exposure to a TPH inhibitor, which blocks 5-HT synthesis, delays and 
prolongs the onset of cell differentiation in some brain regions known to receive 
dense 5-HT innervation. The advancing serotonergic axons also appear to contact 
proliferating cells in the ventricular zone (Wallace & Lauder, 1983) and Cajal-Retzius 
cells in the cortical marginal zone (Janušonis, Gluncic, & Rakic, 2004).  
Many studies have demonstrated the role of 5-HT in developmental cell 
differentiation and growth. In snail cell cultures, some neurons with actively growing 
neurites display inhibition of growth cone activity, suppression of neurite outgrowth, 
and reduced synapse formation following addition of 5-HT to the culture medium 
(Haydon, McCobb, & Kater, 1984; McCobb, Haydon, & Kater, 1988). Another study 
has shown that when snail embryos are exposed to a 5-HT-synthesis inhibitor, cells 
that are normally innervated by 5-HT axons exhibit aberrations in the dendritic 
morphology and in the strength of electrical synaptic connections (Goldberg & Kater, 
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1989). Taken together, 5-HT has a growth-inhibitory effect in the snail nervous 
system.  
Conversely, addition of 5-HT to cultures of rat neurons stimulates neurite 
outgrowth and synaptogenesis. Another study has shown that pharmacological 
depletion of 5-HT with systemic pCPA injections from E12 to E17 or exposure to a 
low-tryptophan diet leads to a decrease in the dendritic arborization of rat cortical 
neurons (González-Burgos, Del Angel-Meza, Barajas-López, & Feria-Velasco, 1996; 
Vitalis, Cases, Passemard, Callebert, & Parnavelas, 2007). The difference between 
the 5-HT effects in these nervous systems may be due to the expressed 5-HTRs, or to 
other differences between invertebrate and vertebrate neurons. Irrespective of the 
specific effects, these studies show the importance of 5-HT in the development and 
differentiation of neural cells.  
Recently, more research has been done to identify which 5-HTRs and 
corresponding mechanisms are involved in these developmental processes. Juvenile 
and adult mice lacking functional 5-HT1ARs exhibit increased arborization of 
hippocampal pyramidal neurons (Cumbo, Mittaud, Ackermann, Hen, & Hornung, 
2008). Similar changes have been observed in mice exposed to a 5-HT1AR antagonist 
from the third to fifth postnatal weeks (Ferreira, Iacono, & Gross, 2010). A study has 
shown that the reduction in dendritic length and spine density in hippocampal neurons 
following exposure to 5-HT depletion can be prevented by administration of a 5-
HT1AR antagonist (Yan, Wilson, & Haring, 1997). Hayashi et al. (2010) have found 
that a 5-HT3R agonist decreases dendritic growth and branching of non-GABAergic 
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cells in the cerebral cortex, and that this effect can be reversed by a 5-HT3R 
antagonist. Activation of 5-HT4R has been shown to cause neurite retraction and cell 
rounding (Ponimaskin, Profirovic, Vaiskunaite, Richter, & Voyno-Yasenetskaya, 
2002), as well as a decrease in the length and number of neurites (Kvachnina et al., 
2005). These findings suggest that the effects of 5-HT in developmental processes are 
highly receptor type-specific.  
Finally, several groups (including ours) have shown that 5-HTRs can be 
expressed by developing brain projections, such as thalamocortical afferents (TCAs) 
(Bonnin, Torii, Wang, Rakic, & Levitt, 2007; Slaten, Hernandez, Albay, Lavian, & 
Janusonis, 2010; Wai, Lorke, Kwong, Zhang, & Yew, 2011). Because 5-HTRs have 
been shown to guide axonal growth during development (Bonnin et al., 2007), 
alterations in 5-HTR expression can lead to axonal mis-wiring. The gain or loss of 
function of certain 5-HTRs at critical developmental periods causes changes in the 
formation of neural connections that last into adulthood. A study by Bonnin et al. 
(2006) has shown that upregulating and downregulating 5-HT1B/1DR expression 
creates two opposing effects. Upregulating 5-HT1B/1DRs causes the TCAs to be 
ventrally shifted/expanded in the internal capsule, while downregulating 5-HT1B/1DRs 
causes the TCAs to follow a more restricted dorsal-medial path. Another neural 
projection that has been studied in this regard is the projection from the rostral RN to 
the PFC. Witteveen et al. (2013) have demonstrated that the serotonergic innervation 
of the mPFC is dramatically increased in rats lacking the 5-HT transporter (5-HTT). 
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These studies support the idea that 5-HT can have a profound influence on the 
formation of specific forebrain circuits.  
5-HT Perturbations in Embryonic Development 
With 5-HT implicated in major developmental processes, it is not surprising that 
prenatal perturbations in the 5-HT system can lead to neurodevelopmental and 
behavioral consequences in the offspring. A series of studies by Vataeva et al. 
(Vataeva, Khozhaĭ, Makukhina, & Otellin, 2007; Vataeva et al., 2008; Vataeva, 
Kudrin, et al., 2007)  have shown that 5-HT depletion with pCPA (para-
chlorophenylalanine, a TPH inhibitor) during embryonic development results in 
abnormal adult behaviors such as locomotor hyperactivity in the open field test, 
increased immobility in the forced swim test, impaired learning in the water maze 
task, hypersensitivity to novel or aversive stimuli, and an increase in saccharin 
preference. Depletion of 5-HT also has led to a significant decrease in the level of a 
DA metabolite (Vataeva et al., 2008), which demonstrates that 5-HT can have a 
strong effect on other neurotransmitter systems. Another study has found that mice 
lacking TPH2, the enzyme responsible for the synthesis of 5-HT in the CNS, exhibit 
increased depression-like behavior, decreased anxiety-like behavior, and 
aggressiveness (Mosienko et al., 2012).  
Prenatal Perturbations: Exposure to Stress and Antidepressants 
There is evidence that the disruption of proper embryonic 5-HT signaling has 
negative consequences for humans. Pregnant women are commonly exposed to 
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factors that can result in altered 5-HT signaling in the fetal brain, including maternal 
stress and antidepressants, such as SSRIs. These two factors can affect the embryonic 
5-HT system, which in turn may lead to behavioral consequences in adolescent and 
adult offspring.  
Many lines of investigation have shown that exposing pregnant women to 
physical and emotional stress can have neurostructural and behavioral effects on the 
offspring, including a predisposition to disorders such as depression, anxiety, 
schizophrenia, and autism spectrum disorder (ASD) (Gillott & Standen, 2007; Koenig, 
Kirkpatrick, & Lee, 2002; Kofman, 2002; Walker, Mittal, & Tessner, 2008). Other 
experiments in mice have shown that prenatal stress (PS) increases 5-HT synthesis in 
the fetal brain (D. A. V. Peters, 1990) and induces region-specific changes in brain 5-
HT and 5-HIAA levels during infancy (Huang et al., 2012; D. A. V. Peters, 1982), 
which can contribute to lasting PS effects. Huang et al. (2012) have shown that 
exposure to chronic unpredictable stress from E0 to E19 results in a decreased ratio of 
5-HIAA to 5-HT, decreased 5-HT1AR mRNA expression, and decreased 5-HTT 
protein expression in the rat embryonic brain at E20. Miyagawa et al. (2011) have 
used the elevated-plus maze and the open field test to show increased anxiety-like 
behavior in mice that have been exposed to PS. In this study, PS-exposed mice spent 
significantly less time in open arms and exhibited less exploratory behaviors in the 
elevated plus maze, indicating an emotional abnormality. This study also has found 
that the adult offspring of PS-exposed mice have morphological changes in 
serotonergic DRN neurons. Specifically, 5-HT- and TPH- immunoreactivities in the 
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DRN appear to be significantly higher in PS-exposed mice compared to control mice. 
van den Hove et al. ( 2011) have reported that heterozygous 5-HTT deficient mice, 
which display a 50% reduction in 5-HTT binding in the brain (Bengel et al., 1998), 
show an increase in depressive-like behavior in female offspring, a reduced basal 
corticosterone level, and impaired object memory performance in all offspring when 
prenatally exposed to restraint stress from E13 to E17. Holloway et al. (2013) 
reported that mice exposed to variable stress conditions from E9 to birth display 
schizophrenia-like behaviors, such as increased head-twitch and locomotor activity, 
and show a decrease in 5-HT2AR expression in the adult frontal cortex. These findings 
indicate that PS-induced alterations of the 5-HT system may contribute to the etiology 
of psychiatric disorders in the offspring.  
Up to 16% of women experience the onset of affective disorders during the 
period of pregnancy (Kitamura, Shima, Sugawara, & Toda, 2009), and various effects 
of prenatal depression on the fetus and newborn have been reported, including 
elevated fetal activity, delayed prenatal growth, prematurity, and low birth weight (T. 
Field, Diego, & Hernandez-Reif, 2006). Currently, the percentage of women using 
antidepressants during pregnancy is around 7-13% and on the rise (S. E. Andrade et 
al., 2008), which leads to a greater focus on the effects of these pharmacological 
agents on prenatal brain development. A number of commonly used SSRIs can 
readily cross the placental barrier and alter 5-HT signaling in the embryo (Rampono 
et al., 2009); SSRIs can also be passed onto neonatal infants through breastfeeding 
(Kristensen et al., 2001). Since the nervous system continues to develop well after 
 18 
 
birth, the neonatal stage is a critical period when 5-HT perturbations can have major 
consequences that may last well into the adult life. The findings reported by prenatal 
SSRI studies are currently somewhat inconsistent (for review, see Kepser & Homberg, 
2014). Some studies have found that prenatal SSRI exposure increases abnormal 
behaviors in adolescent and adult offspring, while others have reported no such 
abnormalities. This may be due to differences in the type and dose of SSRI, the 
dosing interval, the route of administration, the specific developmental period in 
which SSRI exposure occurs, and sample sizes (Kepser & Homberg, 2014). Despite 
this lack of consensus, SSRI exposure during critical developmental times is likely to 
disrupt the development of the 5-HT system. This in turn may lead to an abnormal 
development of critical brain structures and pathways and predispose the offspring to 
maladaptive behavior later in life.  
Stress induced by prolonged maternal separation has reduced 5-HT1AR and 5-
HT2AR mRNA in the mPFC of rat pups (Ohta et al., 2013). Also, chronic prenatal 
exposure of rats to dexamethasone, which mimics PS, has decreased 5-HT1AR mRNA 
in the mPFC at postnatal week 4 (Nagano, Liu, Inagaki, Kawada, & Suzuki, 2012). 
While these results can be viewed as simple homeostatic responses to possibly 
elevated 5-HT (D. A. V. Peters, 1990), the abnormally low 5-HT1AR mRNA levels 
after the dexamethasone treatment have been restored with chronic neonatal treatment 
with fluoxetine (an SSRI), which increases extracellular 5-HT (Nagano et al., 2012). 
In adult rats, chronic treatment with fluoxetine has produced a decrease in 5-HT1AR 
mRNA levels in the cortex (Shishkina, Kalinina, & Dygalo, 2012), and similar 
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treatments with fluoxetine and paroxetine (another SSRI) have reduced 5-HT4R 
binding in the forebrain (Licht et al., 2009; Vidal, Valdizán, Mostany, Pazos, & 
Castro, 2009). It is important to note that the expression levels of 5-HT1AR, 5-HT2AR, 
and 5-HT4R may be interdependent (Fox, Stein, French, & Murphy, 2010; Janušonis, 
2014). In summary, 5-HT signaling may be an important component of the fetal 
programing of mental diseases, which makes it imperative that we understand the 
type and timing of developmental perturbations that can alter 5-HTR expression in 
the developing brain. 
Forebrain Control of the 5-HT System 
In contrast to the wide-spread efferent 5-HT projections, the rostral RN receives 
direct afferent projections from a limited set of brain regions. One major and 
functionally important afferent projection to the DRN is the glutamatergic projection 
that originates in the mPFC, including its infralimbic and prelimbic parts (Aghajanian 
& Wang, 1977; Gabbott, Warner, Jays, Salway, & Busby, 2005; Gonçalves, Nogueira, 
Shammah-Lagnado, & Metzger, 2009; Hajós, Richards, Székely, & Sharp, 1998; 
Sesack, Deutch, Roth, & Bunney, 1989; Vertes, 2004). The mPFC afferents in the 
DRN can make direct synapses with serotonergic neurons, or synapse onto 
GABAergic interneurons (Jankowski & Sesack, 2004) that, in turn, inhibit 
serotonergic neurons (Celada, Puig, Casanovas, Guillazo, & Artigas, 2001; Varga, 
Székely, Csillag, Sharp, & Hajós, 2001). Since this mPFC input can have either direct 
excitatory effects or indirect inhibitory effects on DRN serotonergic neurons, it is 
well-positioned to control their baseline activity. Additionally, mPFC pyramidal cells 
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project to many major brain areas important for cognitive and emotional processes 
(Bossert et al., 2012; J. Peters, Kalivas, & Quirk, 2009; Sesack et al., 1989), thus 
forming a complex regulatory network of neurotransmitter release. 
Serotonergic brain abnormalities have been implicated in a number of brain 
disorders, including ASD (Anderson, 2002; Chugani, 2002, 2004; Whitaker-Azmitia, 
2001), schizophrenia (González-Maeso & Sealfon, 2009; González-Maeso et al., 
2008; Williams et al., 2002), and depression (Carr & Lucki, 2011; Duman, 2007; 
Tamburella et al., 2009). Likewise, altered mPFC function has been implicated in all 
of these disorders (F Artigas, 2010; Courchesne et al., 2007; Drevets, Savitz, & 
Trimble, 2008). A study of autistic brains has shown that they may have a reduced 
number of long-distance axons in the mPFC (Zikopoulos & Barbas, 2010). 
Intriguingly, the mPFC is currently considered to be a part of the brain ―default-mode 
network,‖ a major neural hub that appears to be affected in schizophrenia, depression 
and other brain disorders (Broyd et al., 2009; H. Lu et al., 2012; Zhang & Raichle, 
2010). In this regard, the neurobiology of these disorders may have more in common 
than has been previously thought. The potential importance of the mPFC-DRN 
projection to these disorders has been directly studied or noted by a number of 
researchers (Amat et al., 2005; Amat, Paul, Watkins, & Maier, 2008; F Artigas, 2010; 
Celada, Puig, Martín-Ruiz, Casanovas, & Artigas, 2002; Duman, 2007; Lucas et al., 
2005; Vollenweider & Kometer, 2010).  
Gross et al. (2002) have demonstrated that, in mouse prenatal and early postnatal 
development, normal expression of forebrain 5-HT1ARs is required for the formation 
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of typical (non-anxiety-like) behavior in offspring. This study has used constitutive 
and conditional 5-HT1AR-knockout models and shown that rescuing 5-HT1ARs in the 
forebrain at postnatal day (P) 21) does not result in a significant difference in anxiety-
like behaviors compared to the constitutive knockout mouse. Another study has found 
that increased 5-HT signaling resulting from exposure to SSRIs during P2 to P11 
alters mPFC function in adult mice by reducing the excitability of pyramidal neurons 
in the infralimbic cortex and results in increased anxiety behaviors in the offspring 
(Rebello et al., 2014). Because some infralimbic pyramidal neurons project to the 
DRN, the altered excitability can lead to dysregulated 5-HT synthesis and release.  
Exposure to repeated stress has been shown to have robust effects on the 
branching patterns of apical dendrites in mPFC, including dendritic retraction in the 
prelimbic and infralimbic cortices in the rat brain (Izquierdo, Wellman, & Holmes, 
2006; Radley et al., 2006). In humans, reduced glia and neuron density in the mPFC 
of suicide victims has been reported (Rajkowska, Halaris, & Selemon, 2001). 5-HTRs 
are expressed in the fetal telencephalon before serotonergic axons reach the forebrain, 
including the future mPFC. Since the mPFC eventually projects back to the DRN to 
regulate 5-HT synthesis and release, disruption of the optimal 5-HT supply during 
critical developmental times can affect the proper wiring of the mPFC-DRN 
projection. This in turn may result in an altered dynamic of 5-HT signaling in the 
adult offspring and their abnormal behavioral responses (Figure 1.2).  
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Figure 1.2. The developing forebrain control of the 5-HT system. (A) Exogenous 
and endogenous 5-HT triggers the upregulation of 5-HTR synthesis in the mPFC. 
(B) These receptors control the development of the mPFC-DRN projection. (C) 
The mature mPFC-DRN projection controls 5-HT release in the entire brain.  
Environmental factors such as PS or maternal exposure to SSRIs may affect the 
expression of 5-HTRs in the mPFC and alter the development of the mPFC-DRN 
projection. 
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Specific Aims 
Specific Aim 1: To characterize the effects of repeated perturbations of 
prenatal 5-HT levels on 5-HTR and β2AR mRNA expression in the embryonic 
telencephalon. The 5-HT4R splice variants in the embryonic telencephalon exhibit 
distinct developmental trajectories (Hernandez & Janušonis, 2010) and thus might 
respond differently to prenatal perturbations. Based on these considerations, the 
susceptibility of these splice variants to PS and 5-HT depletion was investigated. Also, 
a region within the 5-HT4R gene contains the gene coding for the adrenergic β2 
receptor (β2-AR) Therefore, it was further investigated whether prenatal 5-HT 
perturbations can affect β2-AR transcription, and, conversely, whether agents 
targeting β2-AR can affect 5-HT4R transcription. Pregnant mice received a 
combination of restraint stress, a TPH inhibitor, a β2-AR agonist, a β2-AR antagonist, 
or a vehicle from E14 to E16, and quantitative reverse-transcription polymerase chain 
reaction (RT-qPCR) was used to assess the mRNA levels of all 5-HT4R splice 
variants (a, b, e, f) and β2AR in the embryonic telencephalon at E17.  
Specific Aim 2: To characterize the effect of acute prenatal 5-HT perturbation 
on 5-HTR mRNA expression in the embryonic telencephalon. Based on the findings 
in Specific Aim 1, it was investigated whether 5-HTRs show a receptor-specific 
susceptibility to acute 5-HT perturbations at specific developmental times. Embryonic 
5-HT levels were perturbed at two developmental times (E14-15 and E16-17) by 
depleting 5-HT with a TPH inhibitor and elevating 5-HT levels with an SSRI, and 
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RT-qPCR was be used to assess the mRNA levels of 5-HT1AR, 5-HT2AR, and all 5-
HT4R splice variants (a, b, e, and f) in the embryonic telencephalon.  
Specific Aim 3: To identify changes in the DRN synaptic structure of mice 
with constitutively altered 5-HT4R expression. The results of Specific Aims 1 and 2 
showed that prenatal 5-HT perturbations can affect the expression of 5-HTRs in the 
developing telencephalon.  Since these alterations can disrupt the normal 
development of major neural projections, it was next investigated how the lack of a 
specific 5-HTR, 5-HT4R, alters the structure and synaptic connectivity of the mPFC-
DRN projection in adult mice. First, the ultrastructural morphology of the DRN of 
adult wild-type (Htr4
+/+
), 5-HT4R-heterozygous (Htr4
+/-
), and 5-HT4R-knockout 
(Htr4
-/-
) mice was examined using electron microscopy. Second, the synaptic 
microstructure of the mPFC projection to the DRN was studied in adult Htr4
+/+
, 
Htr4
+/-
, and Htr4
-/-
 mice using multiple-label immunofluorescence, confocal 
microscopy, and automatic colocalization detection. 
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Chapter 2 
Effects of Prenatal Stress and Monoaminergic Perturbations  
on the Expression of Serotonin 5-HT4 and Adrenergic β2 Receptors  
in the Embryonic Mouse Telencephalon 
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Introduction 
The 5-HT4R is coded by a complex gene that generates at least nine mRNA 
splice variants in humans and pigs and four splice variants in mice (5-HT4(a)R, 5-
HT4(b)R, 5-HT4(e)R, 5-HT4(f)R) (Bockaert et al., 2006, 2004; Claeysen et al., 1999; 
Ray et al., 2009). This receptor shows a highly dynamic expression in the 
development of the mouse and human brain (Lambe, Fillman, Webster, & Shannon 
Weickert, 2011; Manzke, Preusse, Hülsmann, & Richter, 2008; Slaten et al., 2010; 
Waeber, Sebben, Bockaert, & Dumuis, 1996; Waeber, Sebben, Nieoullon, Bockaert, 
& Dumuis, 1994) and, at least in the mouse brain, the 5-HT4R splice variants have 
different developmental trajectories (Hernandez & Janušonis, 2010). This variant-
specificity may carry important temporal and spatial information because 5-HT4R 
splice variants differ in their constitutive activity (Claeysen et al., 2001, 1999), 
internalization properties (Mnie-Filali et al., 2010), and association with intracellular 
proteins (Joubert et al., 2004). 
Altered 5-HT4R function has been associated with ASD (Vincent et al., 2009), 
major depressive disorder (Lucas et al., 2007; Rosel et al., 2004), bipolar disorder 
(Hayden & Nurnberger, 2006), and attention deficit/hyperactivity disorder 
(ADD/ADHD) (J. Li et al., 2006). A recent study has suggested that 5-HT4R is a 
molecular network hub that controls multiple neural processes (Hu, Addington, & 
Hyman, 2011), including those important for the neurobiology of several brain 
disorders. Different levels of 5-HT4R expression have been reported in the amygdala 
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of males and females, which may contribute to sex differences in the prevalence of 
affective disorders (Madsen et al., 2011). 
Evidence suggests that 5-HT4R may be a key component in the forebrain control 
of the brain serotonergic system. Some of this control is mediated by a projection that 
originates in the mPFC and terminates in the DRN (Gabbott et al., 2005; Gonçalves et 
al., 2009; Hajós et al., 1998; Vertes, 2004). In the adult brain, cortical 5-HT4Rs 
modulate the activity of this projection (Bockaert, Claeysen, Compan, & Dumuis, 
2011; Lucas et al., 2005) and can alter brain 5-HT levels by affecting DRN 
serotonergic neurons directly or through GABAergic interneurons (Celada et al., 2001; 
Jankowski & Sesack, 2004). It has implications for a number of brain disorders, 
including the biological action of antidepressants (Lucas et al., 2010; Vidal et al., 
2009). In the embryonic mouse brain, young mPFC neurons express 5-HT4Rs before 
they establish synapses with raphe neurons (Slaten et al., 2010); therefore, a transient 
change in 5-HT4R expression in the fetal mPFC can potentially result in permanent 
dysregulation of 5-HT levels in many brain regions. 
This experiment investigated the effects of maternal PS and 5-HT depletion on 
the mRNA levels of all 5-HT4R splice variants in the embryonic mouse telencephalon. 
Receptor mRNA levels were measured instead of receptor protein levels due to the 
lack of highly specific 5-HT4R antibodies appropriate for quantitative studies. 
Previous studies have shown that maternal stress and serotonergic perturbations can 
cause various alterations in the developing brain (Altamura et al., 2007; Miyagawa et 
al., 2011; D. A. V. Peters, 1990; Vitalis et al., 2007). This experiment also 
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investigated whether maternal stress and other environmental signals can affect 5-
HT4R expression in the embryonic telencephalon by way of β2-ARs. Evidence 
suggests that 5-HT4Rs may be functionally associated with β2-ARs, since the β2-AR 
gene is nested within the 5-HT4R gene (Bockaert et al., 2004) and 5-HT4Rs can form 
heterodimers with β2-ARs (Berthouze et al., 2005, 2007). Also, concerns have been 
raised regarding a possible association between terbutaline (a selective β2-AR agonist 
used to treat preterm labor) and ASD (Witter, Zimmerman, Reichmann, & Connors, 
2009), a disorder in which serotonergic abnormalities have long been noted 
(Anderson, 2002). 
Experimental Procedures 
Animals 
Timed-pregnant C57BL/6 mice were purchased from Charles River Laboratories 
and housed individually on a 12:12 light–dark cycle (lights on at 07:00, off at 19:00) 
with free access to water and food. All procedures have been approved by the UCSB 
Institutional Animal Care and Use Committee. 
Treatment Groups 
Dams were randomly assigned to one of five treatment groups. In the first 
(control) group, dams were given an intraperitoneal (i.p.) injection of saline once 
every day beginning at E14. In the second group, embryonic 5-HT was depleted by 
treating dams with para-chlorophenylalanine (pCPA; Sigma-Aldrich #C3635), a TPH 
inhibitor, dissolved in saline. Based on published reports (Vataeva et al., 2008; Vitalis 
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et al., 2007), dams were given an injection of pCPA (200 mg/kg, i.p.) once every day 
beginning at E14. In the third group, dams were given an intraperitoneal injection of 
saline and immediately exposed to restraint stress by placing them in a 50 mL 
polystyrene centrifuge tube with air-holes for 1 h every day beginning at E14. 
Restraint stress has been used as a controlled stressor in many published studies 
(Darnaudéry, Dutriez, Viltart, Morley-Fletcher, & Maccari, 2004; Holson, Gough, 
Sullivan, Badger, & Sheehan, 1995; Jones et al., 2010; Ribes, Fuentes, Torrente, 
Colomina, & Domingo, 2010; Vallée et al., 1997). In the fourth group, dams were 
exposed to restraint stress as dams in the third group, but instead of saline they were 
given an injection of ICI 118,551, a selective adrenergic β2 antagonist (Sigma-Aldrich 
#I127), dissolved in saline. The dose of ICI 118,551 (2 mg/kg, i.p.) was based on 
published studies (Yalcin et al., 2010; Yu et al., 2010). In the fifth group, dams were 
treated with terbutaline hemisulfate, a selective adrenergic β2 agonist (Sigma-Aldrich 
#T2528), dissolved in saline. Based on published reports (Thaker et al., 2006), dams 
were given an injection of terbutaline (5 mg/kg, i.p.) every day beginning at E14. 
Both terbutaline and ICI 118,551 could reach the embryonic brain because the mouse 
blood-brain barrier matures after birth (Daneman et al., 2010) and it is permeable to 
terbutaline and ICI 118,551 in adulthood (Hsu, Robinson, & Basmadjian, 1994; 
Moresco et al., 2000). In all groups, the injected volume was kept constant (0.5 cm
3
). 
Tissue Collection and RNA Isolation 
At E17, dams were terminally anesthetized with a mixture of ketamine (200 
mg/kg) and xylazine (20 mg/kg), and their uterus was dissected and kept in 0.1 M 
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phosphate-buffered saline (PBS, pH 7.4) on ice. Embryos were removed from the 
uterus, decapitated, and their brains were dissected with a fine forceps under a 
stereoscope. The telencephalon was isolated by carefully transecting the 
telencephalon-diencephalon junction and the total RNA was immediately extracted 
from the telencephalon with the RNeasy Plus Mini Kit (Qiagen) according to the 
manufacturer's instructions. The RNA quality (the A260/A280 ratio) and 
concentration were measured with a NanoDrop spectrophotometer and the samples 
were stored at −75 °C until further processing. From each sample, an estimated 100 
ng of total RNA was reverse-transcribed to cDNA in an Eppendorf Mastercycler pro 
S using the iScript cDNA Kit (Bio-Rad) according to the manufacturer's instructions. 
Three embryos were used from each dam. 
Quantitative RT-PCR Analysis 
The RT-qPCR analysis was based on our published protocol (Hernandez & 
Janušonis, 2010). Five mRNAs of interest (the four 5-HT4R splice variants and β2-AR) 
and three reference (housekeeping) mRNAs (β2-microglobulin, glyceraldehyde-3-
phosphate dehydrogenase, and TATA box binding protein) were analyzed. The 
amplification was performed in a MyiQ single color real-time PCR detection system 
(Bio-Rad). Each PCR reaction (20 μL) was performed in triplicate and contained the 
cDNA equivalent of 20 ng RNA, forward and reverse splice variant-specific primers 
(0.5 μM each; Integrated DNA Technologies, Inc.), 0.2 mM dNTPs, 0.25 U 
PlatinumTaq DNA polymerase (Invitrogen), 0.7X SYBR Green I, and 10 nM 
fluorescein in a PCR buffer containing 10mM Tris–HCl (pH 9.0 at 25 °C), 50mM 
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KCl, 2.5mMMgCl2, and 0.1% Triton X-100. The primers were designed in Beacon 
Designer (Premier Biosoft International) and are given in Table 2.1. The 
amplification conditions were as follows: 94 °C (10min); 45 cycles of 94 °C (10 s), 
56 °C (10 s), 72 °C (90 s), 78 °C (20 s), 82 °C (20 s); 95 °C (1 min); and 60 °C (1 
min). In order to minimize non-specific signal, fluorescence values used in the 
analysis were obtained at the highest available temperature at which no melting of the 
product double-stranded DNA was detected. Controls with no reverse transcription 
indicated no contamination with genomic DNA. 
The efficiency of each amplification was calculated automatically by using a 
Mathematica (Wolfram Research, Inc.) program (Hernandez & Janušonis, 2010) 
based on a published algorithm (Tichopad, Dilger, Schwarz, & Pfaffl, 2003) with 
modifications. Briefly, linear regression was used to model the initial baseline of the 
non-transformed fluorescence data, and the beginning of the exponential phase was 
defined as the amplification cycle in which the first of three consecutive regression 
outliers was detected (the outliers were defined as points whose externally 
studentized residual was significant at the 0.005 level). The exponential phase was 
modeled by linear regression of the log-transformed fluorescence data and the end of 
the exponential phase was defined as the amplification cycle in which the first 
regression outlier was detected (the outlier was defined as the first point whose 
externally studentized residual was significant at the 0.10 level). The mRNA amount 
in the initial tissue sample was calculated as the triplicate mean of (RFU−baseline) × 
E
−x
, where baseline is the mean baseline fluorescence before the exponential phase, x 
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mRNA 
accession 
Target 
mRNA 
Forward primer (5’-3’) Reverse primer (5’-3’) bp E 
Y09587 5-HT4(a)R ATCCTCTGCTGTGAT
GATGAG 
ACTGTGCAAAACTGT
ATACCTTAG 
120 1.696 
Y09585 5-HT4(b)R CCTGGACAATGACCT
AGAAGAC 
TTGCCTCTGCTCTTG
GAAAG 
121 1.734 
Y09588 5-HT4(e)R ATCCTCTGCTGTGAT
GATGAG 
GGAACAGGTCTATT
GCGGAAG 
134 1.713 
AJ011369 5-HT4(f)R ACCTGTTCCCGTCTA
ACTGAG 
TAGTAACCTGTTCAT
GCAGACAC 
190 1.766 
NM_007420 β2-AR TCTGTCTGTCTGTCT
GGATGATG 
CCCATTGTCACAGCA
GAAAGG 
167 1.731 
NM_009735 
(reference) 
B2M GGAGAATGGGAAGC
CGAACATAC 
AGAAAGACCAGTCC
TTGCTGAAG 
143 1.812 
NM_008084 
(reference) 
GAPDH AATGTGTCCGTCGTG
GATCTGA 
AGTGTAGCCCAAGA
TGCCCTTC 
117 1.794 
NM_013684 
(reference) 
TBP GATCTTTGCAGGCAA
GCAGCT 
TTCTCTATGGTGTCA
CTGGGCTC 
197 1.801 
 
 
Table 2.1. The quantitative RT-PCR primers and the amplification efficiencies. Since 
amplification efficiencies depend only on primers and amplification conditions, all 
experimental conditions were used to obtain the estimates. Abbreviations: bp, 
amplicon length in base pairs; E, mean amplification efficiency; B2M, β2-
microglobulin; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; TBP, TATA 
box binding protein. 
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and RFU are the cycle number and the fluorescence at the mid-point of the 
exponential phase, and E is the amplification efficiency of the mRNA species. The 
normalized mRNA amount was calculated by dividing the mRNA amount by the 
geometric mean of the mRNA amounts of the reference genes in the same sample 
(Vandesompele et al., 2002). For convenience, the obtained value was multiplied by 
1000. 
Statistical Analysis 
Statistical analyses were performed in R 2.14 (The R Foundation for Statistical 
Computing) and in IBM SPSS 19 (IBM, Inc.). Mixed-effects models were analyzed 
with the R nlme package (Pinheiro, Bates, DebRoy, Sarkar, & Team, 2013) and non-
homogeneity of variances was accounted for by choosing the varIdent variance 
structure (Zuur, Ieno, Walker, Saveliev, & Smith, 2009). These approaches are 
superior to traditional statistical tests that are based on mathematical convenience 
rather than biological relevance and are strongly recommended for experimental 
research in neuroscience (Lazic, 2010; Nakagawa & Hauber, 2011). By following a 
well-established procedure (Zuur et al., 2009), statistical models were built 
sequentially by using restricted maximum likelihood estimation (REML) and 
maximum likelihood estimation (ML): (i) first, a ―beyond optimal‖ model was 
constructed that included all relevant fixed effects; (ii) the structure of variances and 
random effects was optimized by comparing nested REML-fitted models with 
ANOVA and testing the significance of the likelihood ratios (L) (in mixed-effects 
analyses, the significance of L was calculated ―on the boundary‖); (iii) the structure of 
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fixed effects was optimized by comparing nested ML-fitted models with ANOVA 
and testing the significance of L (the nonsignificant fixed effects were removed); (iv) 
the final model was refitted with REML and validated (tested for the normality and 
homogeneity of residuals). In all tests, the significance level was set at 0.05. For post-
hoc analyses, the Bonferroni correction was used. 
Results 
Effects of PS, β2-AR Agents, and 5-HT Depletion on β2-AR mRNA Levels 
Since the transcription of the 5-HT4R gene can potentially be affected by the 
transcription of the β2-AR gene due to the nested arrangement of the genes (Gibson, 
Thomson, Abrams, & Kirkham, 2005; Lucas et al., 2005), we first investigated 
whether the β2-AR mRNA amount in the embryonic telencephalon was altered by 
any of the treatments used in the study (maternal PS, selective β2-AR agents 
(terbutaline and ICI 118,551), and 5-HT depletion with pCPA) (see Figure 2.1). The 
initial statistical model included these conditions as the fixed effect (Treatment). 
Adding a random litter effect to the intercept significantly improved the model 
(L=16.8, p<0.0001). Allowing each condition to have a different variance did not 
further improve the model (L=4.60, df=4, p>0.3). The final validated model revealed 
no significant Treatment effect (F(4,17)=0.65, p=0.63). In summary, the analysis 
indicated the presence of inter-litter variability in the baseline β2-AR mRNA levels 
(with an estimated standard deviation of 17% of the baseline), but these levels were 
not significantly altered by any of the used experimental perturbations. 
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Figure 2.1. Effects of PS, β2-AR agents, and 5-HT 
depletion on β2-AR mRNA levels. The normalized 
β2-AR mRNA amounts in the telencephalon of 
embryos (E17) from control dams injected with 
saline (Control) and from dams (i) injected with 
saline and exposed to maternal prenatal stress 
(Stress), (ii) injected with a β2-AR antagonist and 
exposed to maternal prenatal stress (ICI 
118,551+Stress), (iii) injected with a β2-AR agonist 
(Terbutaline), and (iv) injected with a TPH inhibitor 
(pCPA). Error bars = SEM. 
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Effects of PS and β2-AR Agents on 5-HT4R Splice Variants 
We next examined whether maternal restraint stress and a selective β2-AR 
agonist (terbutaline) affect the mRNA levels of the 5-HT4R splice variants in the 
embryonic telencephalon. We also investigated whether a selective β2-AR antagonist 
(ICI 118,551), administered prior to restraint stress, attenuates stress effects on 5-
HT4R mRNA levels (see Figure 2.2). The selective β2-AR agents were included 
because stress-related signals can act on β2-ARs (Qu, Guo, & Li, 2008), β2-ARs have 
been shown to form heterodimers with 5-HT4Rs (Berthouze et al., 2005, 2007), and 
the activity of one receptor in a heterodimer can affect the internalization and 
trafficking of the other receptor, with potential changes in its transcription (Renner et 
al., 2012; Rozenfeld & Devi, 2011). The initial statistical model (with Variant, 
Treatment, and Variant×Treatment as the fixed effects) was significantly improved by 
allowing each splice variant to have a different variance (L=215.8, df=3, p<0.0001) 
and was further improved by adding correlations (compound symmetry) among all 
splice variants (L=87.7, df=1, p<0.0001). No further improvement was obtained by 
adding a random litter effect to the intercept (L=10
−7
, p>0.4), suggesting no 
variability among the litters. The final validated model showed no significant 
Variant×Treatment interaction (F(9,212)=1.60, p=0.12) and no Treatment effect in 
the absence of the interaction term (F(3,221)=0.34, p=0.79). 
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Figure 2.2. The effects of PS and β2-AR agents on the 5-HT4R splice variants. (A) 
The normalized mRNA amounts of the four 5-HT4R splice variants in the 
telencephalon of embryos (E17) from control dams injected with saline (Control) and 
from dams (i) injected with saline and exposed to maternal prenatal stress (Stress), (ii) 
injected with a β2-AR antagonist and exposed to maternal prenatal stress (ICI 
118,551+Stress), and (iii) injected with a β2-AR agonist (Terbutaline). (B) The data 
obtained by pooling the two treatments with no stress (Control and Terbutaline) and 
the two treatments with stress (Stress and ICI 118,551+Stress). Error bars = SEM; 
*p<0.012 (after the Bonferroni correction for the four comparisons (0.05/4)). 
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Since similar differences were observed between stressed and unstressed 
embryos irrespective of whether or not they had been treated with the selective β2-AR 
agents (see Figure 2.2A), we next combined these data into two groups disregarding 
the β2-AR treatment (see Figure 2.2B). This approach was further supported by the 
finding that neither the β2-AR agonist nor the β2-AR antagonist had a significant 
effect on the β2-AR mRNA levels (see Figure 2.1). Also, the correlations between the 
β2-AR mRNA levels and the mRNA levels of each 5-HT4R splice variant were not 
significantly different from zero, in contrast to the strong correlations among the 5-
HT4R splice variants (see Table 2.2). The two pooled conditions (no stress and stress) 
produced the same structure of the statistical model (the initial model: Variant, 
Treatment, Variant×Treatment; different variances for each splice variant: L=229.5, 
df=3, p<0.0001; correlations between the variants: L=90.9, df=1, p<0.0001; a random 
litter effect added to the intercept: L=10
−7
, p>0.4). In the final validated model, the 
Variant×Treatment interaction was significant (F(3,220)=2.80, p=0.04). There was no 
Treatment effect in the absence of the interaction (F(1,223)=0.57, p=0.45). Consistent 
with this finding, only the decrease in the 5-HT4(b)R levels was significant after the 
Bonferroni correction for the four comparisons (5-HT4(a)R: t(55)=2.25, p=0.028; 5-
HT4(b)R: t(55)=2.83, p=0.007; 5-HT4(e)R: t(55)=2.55, p=0.014; 5-HT4(f)R: t(55)=2.09, 
p=0.041). The decrease in 5-HT4(b)R mRNA was 20%. 
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 5-HT4(b)R 5-HT4(e)R 5-HT4(f)R β2-AR 
5-HT4(a)R 0.579* 
(p<10
−6
) 
0.707* 
(p<10
−10
) 
0.756* 
(p<10
−12
) 
0.059 
(p=0.64) 
5-HT4(b)R  0.478* 
(p<10
−4
) 
0.472* 
(p<10
−4
) 
0.061 
(p=0.63) 
5-HT4(e)R   0.576* 
(p<10
−6
) 
0.066 
(p=0.60) 
5-HT4(f)R    0.067 
(p=0.59) 
 
Table 2.2. The correlations between the mRNA amounts of the 5-HT4R 
splice variants and β2-AR at E17. Since correlation measures only 
association strength, all experimental conditions were used. In each 
cell, the top number is the Pearson correlation (65 cases) and the 
bottom number is the p-value. By taking into account the Bonferroni 
correction for the ten cross-correlations, the significance level was set 
at 0.005 (*). 
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Effects of 5-HT Depletion on 5-HT4R Splice Variants 
We next assessed the susceptibility of all 5-HT4R splice variants to low 5-HT 
levels in the developing brain. Depletion of 5-HT with pCPA strongly reduced the 
mRNA amount of the 5-HT4(b)R splice variant in the embryonic telencephalon, with 
virtually no effect on the other three 5-HT4R splice variants (see Figure 2.3).  
The initial statistical model (with Variant, Treatment, and Variant×Treatment as 
the fixed effects) was significantly improved by allowing each splice variant to have a 
different variance (L=86.7, df=3, p<0.0001). Adding correlations between all splice 
variants further improved the model (L=27.1, df=1, p<0.0001). Adding a random 
litter effect to the intercept did not further improve the model (L=0.023, p>0.4), 
suggesting no significant variability among the litters. The Variant×Treatment 
interaction in the final validated model was highly significant (F(3,92)=4.65, 
p=0.0045). The decrease in 5-HT4(b)R mRNA was 37% and significant after the 
Bonferroni correction for the four comparisons (t(23)=3.14, p=0.005). The 
Variant×Treatment interaction remained significant if the data were analyzed with a 
mixed-design ANOVA with the Greenhouse–Geisser correction (A. Field, 2009), to 
account for the violation of the sphericity assumption (F(1.8,41.4)=3.72, p=0.037). 
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Figure 2.3. The effects of 5-HT depletion on the 5-HT4R 
splice variants. The normalized mRNA amounts of the 5-
HT4R splice variants in the telencephalon of embryos 
(E17) from control dams and from dams treated with 
pCPA. Error bars = SEM; *p<0.012 (after the Bonferroni 
correction for the four comparisons (0.05/4)). 
 
 
 
 42 
 
Discussion 
The obtained results demonstrate that PS and reduced 5-HT levels can alter 5-
HT4R expression in the developing telencephalon and that some 5-HT4R splice 
variants may be more susceptible than others. They also suggest that these effects are 
not mediated or modulated by β2-AR receptors. 
Binding studies in the adult brain have found that altered 5-HT levels typically 
cause compensatory changes in the availability of 5-HT4Rs to ligands. On the one 
hand, an increase in 5-HT4R binding has been observed in some brain regions of adult 
rats and young pigs following 5-HT depletion with pCPA (Ettrup, Kornum, Weikop, 
& Knudsen, 2011; Licht et al., 2009) and in mice overexpressing the 5-HTT 
(Jennings et al., 2012). On the other hand, a decrease in 5-HT4R binding has been 
observed in the adult rat brain following chronic treatment with the selective 5-HT 
reuptake inhibitors fluoxetine and paroxetine (Licht et al., 2009; Vidal et al., 2009) 
and in knockout mice lacking 5-HTT (Jennings et al., 2012). PS can increase 5-HT 
levels in the embryonic rat brain (D. A. V. Peters, 1990) and it may also increase the 
number of 5-HT immunoreactive neurons in the adult brains of prenatally exposed 
mice (Miyagawa et al., 2011). Taken together, these results appear to indicate that PS 
is likely to decrease 5-HT4R expression in the embryonic telencephalon and that 5-
HT depletion is likely to increase it. 
Our results are not consistent with these predictions and suggest a more complex 
developmental mechanism. Both maternal stress and 5-HT depletion caused a 
decrease in 5-HT4R mRNA levels, even though the strength of the effect varied 
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among the conditions and splice variants. These shifts are remarkably similar to the 
results obtained in another study that has investigated 5-HT1ARs in the developing rat 
brain (Lauder, Liu, & Grayson, 2000). In this study, prenatal exposure to 5-
methoxytryptamine (5-MT), a non-specific 5-HTR agonist, has caused a moderate 
(but significant) decrease in 5-HT1AR mRNA levels and prenatal depletion of 5-HT 
with pCPA has reduced 5-HT1AR mRNA levels by nearly 50%. These changes are 
comparable to our findings not only in their direction, but also in their relative 
magnitudes (Figures 2.2B and 2.3). Taken together, these findings suggest that, in 
development, the expression of at least some 5-HTRs requires an optimal 5-HT level 
and that a deviation from this optimum may result in a lower number of mRNA 
transcripts. Abnormally low or high 5-HT levels may induce this change through the 
same mechanism or two different mechanisms. For example, low 5-HT levels might 
result in a failure to developmentally upregulate mRNA levels, perhaps in a splice-
specific manner (Hernandez & Janušonis, 2010), whereas high 5-HT levels might 
lead to compensatory downregulation of mRNA levels. Generally, quantitative 
relationships between mRNA transcripts and receptor availability can be complex or 
counterintuitive due to the dynamics of the system (Janušonis, 2012a). In this regard, 
several technical considerations are important for the interpretation of our and other 
related studies. 
Most published studies have examined 5-HT4R binding, whereas receptor 
mRNA levels were analyzed in our study and in Lauder et al. (2000). The measures 
obtained by these two technical approaches are not directly comparable. First, 5-
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HT4R binding can change due to receptor internalization and recycling (Mnie-Filali et 
al., 2010), with no change in mRNA levels. Second, mRNA analysis cannot detect 5-
HT4Rs on the terminals of long-range projections that originate outside the 
telencephalon. There is strong evidence that 5-HT4Rs can be expressed not only 
postsynaptically, but also presynaptically in distal axonal segments (Slaten et al., 
2010; Vilaró, Cortés, & Mengod, 2005). Third, binding studies cannot distinguish 
among 5-HT4R splice variants; therefore, changes affecting only some of the variants 
can be masked by other, abundantly expressed variants. 
A recent study has shown that early forebrain development depends on maternal 
5-HT signals that reach the embryo through the placenta (Bonnin et al., 2011). While 
no information is currently available about how placental 5-HT synthesis is affected 
by maternal stress, pCPA is known to inhibit placental 5-HT synthesis (Bonnin et al., 
2011). It cannot be ruled out that placental 5-HT might have contributed to our 
findings, but we note that all experimental treatments began at E14, around the time 
when the mouse forebrain begins to switch to its endogenous 5-HT source, brainstem 
serotonergic afferents (Bonnin & Levitt, 2011). 
The relatively small effect of maternal stress on 5-HT4R levels may be due to the 
restraint length (one hour per day), which was low in comparison to that used in other 
reports. Daily restraint stress for a total of 1.5–3.0 h is considered standard or ―weak‖ 
(Darnaudéry et al., 2004; Holson et al., 1995; Miyagawa et al., 2011; Ribes et al., 
2010; Vallée et al., 1997), and some researchers have used daily six-hour exposures 
to produce ―strong‖ PS (Miyagawa et al., 2011). However, such long exposures 
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increase the contribution of various confounding factors, such as muscle fatigue, 
thermoregulation, blood circulation, and food intake, and may consequently reduce 
the relevance of the findings to human research. Achieving an optimal balance 
between experimental effects in rodents and relevance for human research will 
require a better understanding of the dose-dependent effects of maternal PS 
(Mychasiuk, Ilnytskyy, Kovalchuk, Kolb, & Gibb, 2011). 
The susceptibility of the 5-HT4(b)R splice variant to altered 5-HT levels is 
interesting because in the adult brain this variant is readily internalized and recycled 
(Mnie-Filali et al., 2010). Consequently, it is well positioned to rapidly respond to 
fluctuations of 5-HT levels at the protein level and may depend on a relatively stable 
mRNA pool. If the reduced availability of 5-HT4(b)R mRNA persists into adulthood, it 
may have implications for brain disorders associated with dysfunction of 5-HT 
homeostasis. 
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Chapter 3 
Transcriptional Responses of Serotonin Receptors in the  
Embryonic Mouse Forebrain to Acute Changes of Prenatal Serotonin Levels 
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Introduction 
Forebrain 5-HTRs support various neural functions, including global brain states 
(R. E. Brown, Basheer, McKenna, Strecker, & McCarley, 2012; Jacobs & Azmitia, 
1992), and have been implicated in a number of mental disorders, such as depression, 
obsessive-compulsive disorder, schizophrenia, ASDs, and others (Azmitia et al., 2011; 
Fribourg et al., 2011; Vollenweider & Kometer, 2010). This experiment focused on 
three 5-HTRs, 5-HT1AR, 5-HT2AR, and 5-HT4R, all of which are expressed in the 
forebrain (R. Andrade, 2011; Suwa, Bock, Preusse, Rothenberger, & Manzke, 2014). 
The mouse 5-HT4R gene produces four splice variant (5-HT4(a)R, 5-HT4(b)R, 5-
HT4(e)R, 5-HT4(f)R) that differ in their functional properties (Claeysen et al., 1999; 
Mnie-Filali et al., 2010). In the mPFC, these receptors control the activity of the 
direct prefrontal projection to the DRN (Hajós et al., 1998; Soiza-Reilly & Commons, 
2011a) and modulate the dynamics of 5-HT signaling in the brain (Celada et al., 2002; 
Hajós, Hajós-Korcsok, & Sharp, 1999; Holmes, 2008; Lucas et al., 2005).  
In the developing human brain, the expression of 5-HT receptors is likely to be 
affected by environmental exposures. We therefore investigated whether the 
expression of 5-HT1AR, 5-HT2AR, and 5-HT4R in the embryonic telencephalon is 
affected by acute prenatal exposures to an SSRI  and a 5-HT synthesis inhibitor. 
Since the mouse 5-HT4R gene produces four mRNA splice variants (5-HT4(a)R, 5-
HT4(b)R, 5-HT4(e)R, 5-HT4(f)R) that differ in their functional properties (Claeysen et 
al., 1999; Mnie-Filali et al., 2010), we analyzed these splice variants separately. 
Acute exposures were used because chronic models reflect near-equilibrium states 
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and can be fundamentally misleading, especially in the inherently dynamic 
developmental processes (Janušonis, 2012b; Kumar, Vlachos, Aertsen, & Boucsein, 
2013). 
Based on the experimental and conceptual considerations presented in Chapter 1, 
this experiment sought to understand the immediate mRNA responses of 5-HT1AR, 5-
HT2AR, and 5-HT4R in the mouse telencephalon to acute alterations of prenatal 5-HT 
levels. 
Experimental Procedures 
Animals  
Timed-pregnant C57BL/6 mice were purchased from Charles River Laboratories 
and housed individually on a 12:12 light-dark cycle with free access to water and 
food. All procedures have been approved by the UCSB Institutional Animal Care and 
Use Committee.   
Treatment Groups 
Dams were randomly assigned to one of the six groups, each of which 
represented one of the two embryonic developmental times and one of the three 
treatments. In the morning of either E14 or E16, dams were given a single 
intraperitoneal (i.p.) injection of one of the following: (i) saline, (ii) pCPA (Sigma-
Aldrich C3635; dissolved in saline), or (iii) fluoxetine hydrochloride (Sigma-Aldrich 
F132; dissolved in saline). The doses of pCPA (200 mg/kg) and fluoxetine (0.5 mg/kg) 
were based on published reports that have used these agents in studies of rodent 
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embryonic development (Kornum, Licht, Weikop, Knudsen, & Aznar, 2006; 
Noorlander et al., 2008; Smit-Rigter et al., 2012; Vataeva et al., 2008; Vitalis et al., 
2007). Both pCPA and fluoxetine have a high placental transfer (Lauder & Krebs, 
1976; Noorlander et al., 2008; Rampono et al., 2009; Vitalis et al., 2007). Consistent 
with previous reports (Noorlander et al., 2008; Vitalis et al., 2007), embryos showed 
no gross developmental abnormalities.  
Tissue Collection and RNA Isolation 
Twenty-four hours after the injection, dams were terminally anesthetized with a 
mixture of ketamine (200 mg/kg) and xylazine (20 mg/kg), and their uterus was 
dissected and kept in 0.1M PBS on ice. Embryos were removed from the uterus, 
decapitated, and their brains were dissected with fine forceps under a stereoscope. 
The telencephalon was isolated by transecting the telencephalon-diencephalon 
junction, and the total RNA was immediately extracted from the telencephalon with 
the RNeasy Plus Mini Kit (Qiagen) according to the manufacturer’s instructions. The 
RNA quality (the A260/A280 ratio) and concentration were measured with a 
NanoDrop spectrophotometer and the samples were stored at −75ºC until further 
processing. From each sample, an estimated 100 ng of total RNA was reverse-
transcribed to cDNA in an Eppendorf Mastercycler pro S using the iScript cDNA Kit 
(Bio-Rad) according to the manufacturer’s instructions. Three embryos were used 
from each dam, which were assigned unique numbers for further analyses of litter 
effects. 
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Quantitative RT-PCR Analysis 
The quantitative (real-time) reverse-transcription polymerase chain reaction 
(RT-qPCR) analysis was based on our published protocol (Chen, Kelley, & Janušonis, 
2012). Six mRNAs of interest (5-HT1AR, 5-HT2AR, and the four 5-HT4R splice 
variants) and two reference mRNAs (glyceraldehyde-3-phosphate dehydrogenase and 
ubiquitin C) were analyzed. The amplification was performed in a MyiQ single color 
real-time PCR detection system (Bio-Rad) or in a CFX96 Touch real-time PCR 
detection system (Bio-Rad). Each PCR reaction (20 µL) was performed in triplicate 
and contained the cDNA equivalent of 20 ng RNA, forward and reverse splice 
variant-specific primers (0.5 µM each; Integrated DNA Technologies, Inc.), 0.2 mM 
dNTPs, 0.25 U Platinum Taq DNA polymerase (Invitrogen), 0.7X SYBR Green I, 
and 10 nM fluorescein in a PCR buffer containing 10 mM Tris-HCl (pH 9.0 at 25ºC), 
50 mM KCl, 2.5 mM MgCl2, and 0.1% Triton X-100. The primers were designed in 
Beacon Designer (Premier Biosoft International) and Primer-BLAST (National 
Center for Biotechnology Information) and are given in Table 3.1. The amplification 
conditions were as follows: 94ºC (10 min); 45 cycles of 94ºC (10 sec), 56ºC (10 sec), 
72ºC (90 sec), 78ºC (20 sec), 82ºC (20 sec); 95ºC (1 min); 60ºC (1 min). In order to 
minimize non-specific signal, fluorescence values used in the analysis were obtained 
at the highest available temperature at which no melting of the product double-
stranded DNA was detected (for all mRNAs, this temperature was 82ºC).  
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mRNA 
accession 
Target 
mRNA 
Forward primer  
(5’-3’) 
Reverse primer  
(5’-3’) 
bp E 
NM_008308 5-HT1AR CAGCGCGAGACA
GATATTAC 
CATCTGAGAGGA
GCACTCAC 
152 1.802 
NM_172812 5-HT2AR TGACTGATTCCTC
TCTGTGC 
CCCCTCTCTTTGA
GCTTCTA 
196 1.798 
Y09587 5-HT4(a)R ATCCTCTGCTGTG
ATGATGAG 
ACTGTGCAAAAC
TGTATACCTTAG 
120 1.800 
Y09585 5-HT4(b)R CCTGGACAATGA
CCTAGAAGAC 
TTGCCTCTGCTCT
TGGAAAG 
121 1.799 
Y09588 5-HT4(e)R ATCCTCTGCTGTG
ATGATGAG 
GGAACAGGTCTA
TTGCGGAAG 
134 1.810 
AJ011369 5-HT4(f)R ACCTGTTCCCGTC
TAACTGAG 
TAGTAACCTGTTC
ATGCAGACAC 
190 1.804 
NM_008084 
(reference) 
GAPDH AATGTGTCCGTCG
TGGATCTGA 
AGTGTAGCCCAA
GATGCCCTTC 
117 1.770 
NM_019639 
(reference) 
UBC GATCTTTGCAGGC
AAGCAGCT 
TTCTCTATGGTGT
CACTGGGCTC 
174 1.740 
 
Table 3.1. The primer sequences for the RT-qPCR. Abbreviations: bp, amplicon 
length in base pairs; E, mean amplification efficiency; GAPDH, Glyceraldehyde-3-
phosphate dehydrogenase; UBC, Ubiquitin C. 
 
 
 
 52 
 
The efficiency of each amplification was calculated automatically by using a 
Mathematica (Wolfram Research, Inc.) program (Hernandez & Janušonis, 2010) 
based on a published algorithm (Tichopad et al., 2003) with modifications. Briefly, 
linear regression was used to model the initial baseline of the non-transformed 
fluorescence data, and the beginning of the exponential phase was defined as the 
amplification cycle in which the first of three consecutive regression outliers was 
detected (the outliers were defined as points whose externally studentized residual 
was significant at the 0.005 level). The exponential phase was modeled by linear 
regression of the log-transformed fluorescence data and the end of the exponential 
phase was defined as the amplification cycle in which the first regression outlier was 
detected (the outlier was defined as the first point whose externally studentized 
residual was significant at the 0.10 level). The mRNA amount in the initial tissue 
sample was calculated as the triplicate mean of (RFU – baseline)×E−x, where baseline 
is the mean baseline fluorescence before the exponential phase, x and RFU are the 
cycle number and the fluorescence at the mid-point of the exponential phase, and E is 
the mean amplification efficiency of the mRNA species. The normalized mRNA 
amount was calculated by dividing the mRNA amount by the geometric mean of the 
mRNA amounts of the reference genes in the same sample (Vandesompele et al., 
2002). For convenience, the obtained value was multiplied by 1000.   
Statistical Analysis 
For statistical analyses, normalized mRNA amounts were log-transformed. This 
was done to avoid an interaction effect if two different expression baselines (E15 and 
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E17) were altered by comparable factors (without this transformation, a change from 
1 to 2 and a change from 10 to 20 would be treated as different by additive statistical 
models). Statistical analyses were performed in R 3.0.2 (The R Foundation for 
Statistical Computing) and in IBM SPSS 19 (IBM, Inc.). Mixed-effects models were 
analyzed with the R nlme package (Pinheiro et al., 2013) and non-homogeneity of 
variances was included in statistical models by choosing the varIdent variance 
structure (Chen et al., 2012; Flood et al., 2012; Zuur et al., 2009). In contrast to 
traditional tests motivated by mathematical simplicity, these statistical approaches are 
biologically-oriented and are strongly recommended for experimental research in 
neuroscience (Lazic & Essioux, 2013; Lazic, 2010; Nakagawa & Hauber, 2011). By 
following a recommended procedure (Zuur et al., 2009), statistical models were built 
sequentially by using restricted maximum likelihood estimation (REML) and 
maximum likelihood estimation (ML): (i) first, a ―beyond optimal‖ model was 
constructed that included all relevant fixed (deterministic) effects; (ii) the structure of 
variances and random effects was optimized by comparing nested REML-fitted 
models with ANOVA and testing the significance of the likelihood ratios (L) (in 
mixed-effects analyses, the significance of L was calculated ―on the boundary‖); (iii) 
the structure of fixed effects was optimized by comparing nested ML-fitted models 
with ANOVA and testing the significance of L (the non-significant fixed effects were 
removed); (iv) the final model was refitted with REML and validated (tested for the 
normality of residuals with the Shapiro-Wilk test and for the homogeneity of 
residuals with the Fligner-Killeen and Bartlett tests). The effects of individual 
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treatments were assessed by estimating the significance of the coefficients at the 
appropriate dummy variables in the final model. In all tests, the significance level was 
set at 0.05. 
Results 
Experimental Groups 
This experiment investigated whether acute changes in prenatal 5-HT levels alter 
5-HT4R expression in the embryonic telencephalon. Since in the adult brain DRN-
projecting mPFC neurons are also strongly modulated by 5-HT1AR and 5-HT2AR, 
these receptors were added to the set.  
Timed-pregnant mice were pharmacologically treated at E14 or E16 with a 
pCPA or an SSRI (fluoxetine) to achieve a decrease or increase in extracellular 5-HT 
levels, respectively. After 24 hours, the mRNA levels of 5-HT1AR, 5-HT2AR, and the 
four 5-HT4R splice variants were quantified in the embryonic telencephalon Figures 
3.1 and 3.2.). 
5-HT1AR Expression  
In the analysis of 5-HT1AR expression, allowing the variance to depend on Age 
or Treatment did not significantly improve the statistical model (L(1) = 0.22, p = 0.64 
and L(2) = 4.95, p = 0.08, respectively). The model was significantly improved when 
the intercept (the baseline mRNA expression) was allowed to randomly vary across 
litters (p = 0.0004; the estimated standard deviation of this variation was 0.087). In 
the presence of the litter effects, the Age×Treatment interaction was not significant  
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Figure 3.1. The mRNA amounts of the 5-HT1AR and 5-HT2AR in the telencephalon 
of embryos prenatally exposed to pCPA and fluoxetine for 24 hours (E14-15 and 
E16-17). Error bars = SEM; the plotted means assume independence among data 
points. In statistical analyses, litter effects were included. 
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Figure 3.2. The mRNA amounts of the 5-HT4R splice variants in the telencephalon 
of embryos prenatally exposed to pCPA and fluoxetine for 24 hours (E14-15 and 
E16-17). Error bars = SEM; the plotted means assume independence among data 
points. In statistical analyses, litter effects were included. 
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(L(2) = 1.60, p = 0.45). Without the interaction term, the overall Treatment effect was 
significant (L(2) = 54.4, p < 0.0001). Taken separately, only the fluoxetine treatment 
significantly affected 5-HT1AR mRNA levels (t(17) = −11.1, p < 0.0001), but the 
pCPA treatment had no significant effect (t(17) = 1.50, p = 0.15).     
5-HT2AR Expression 
In the analysis of 5-HT2AR expression, allowing the variance to depend on Age 
and Treatment significantly improved the model (L(5) = 63.7, p < 0.0001). The model 
was further improved when the intercept was allowed to randomly vary across litters 
(p = 0.002; the estimated standard deviation of this variation was 0.217). In the 
presence of the litter effects, the Age×Treatment interaction was not significant (L(2) 
= 5.76, p = 0.06). Without the interaction term, the overall Treatment effect was 
significant (L(2) = 14.8, p = 0.0006). Taken separately, only the fluoxetine treatment 
significantly affected 5-HT2AR mRNA levels (t(17) = −2.87, p = 0.01), but the pCPA 
treatment had no significant effect (t(17) = 0.95, p = 0.35).      
5-HT4(a)R Expression 
In the analysis of 5-HT4(a)R expression, allowing the variance to depend on Age 
or Treatment did not significantly improve the model (L(1) = 0.31, p = 0.58 and L(2) 
= 2.04, p = 0.36, respectively). The model was significantly improved when the 
intercept was allowed to randomly vary across litters (p = 0.015; the estimated 
standard deviation of this variation was 0.050). In the presence of the litter effects, the 
Age×Treatment interaction was not significant (L(2) = 4.01, p = 0.13). Without the 
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interaction term, the overall Treatment effect was significant (L(2) = 69.6, p < 
0.0001). Taken separately, only the fluoxetine treatment significantly affected 5-
HT4(a)R mRNA levels (t(17) = −16.8, p < 0.0001), but the pCPA treatment had no 
significant effect (t(17) = 1.51, p = 0.15).     
5-HT4(b)R Expression 
In the analysis of 5-HT4(b)R expression, allowing the variance to depend on Age 
did not significantly improve the model (L(1) = 0.043, p = 0.84), but the model was 
significantly improved when the variance was allowed to depend on Treatment (L(2) 
= 13.2, p = 0.001). The model was further improved when the intercept was allowed 
to randomly vary across litters (p = 0.005; the estimated standard deviation of this 
variation was 0.116). In the presence of the litter effects, the Age×Treatment 
interaction was not significant (L(2) = 1.75, p = 0.42). Without the interaction term, 
the overall Treatment effect was significant (L(2) = 45.3, p < 0.0001). Taken 
separately, only the fluoxetine treatment significantly affected 5-HT4(b)R mRNA 
levels (t(17) = −8.38, p < 0.0001), but the pCPA treatment had no significant effect 
(t(17) = 1.54, p = 0.14).     
5-HT4(e)R Expression 
In the analysis of 5-HT4(e)R expression, allowing the variance to depend on Age 
did not significantly improve the model (L(1) = 2.57, p = 0.11), but the model was 
significantly improved if the variance was allowed to depend on Treatment (L(2) = 
9.74, p = 0.008). The model was further improved when the intercept was allowed to 
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randomly vary across litters (p = 0.004; the estimated standard deviation of this 
variation was 0.084). In the presence of the litter effects, the Age×Treatment 
interaction was only marginally significant (L(2) = 6.60, p = 0.04) and, considering 
the lack of this effect in the other five genes, was not included in the final model. 
Without the interaction term, the overall Treatment effect was significant (L(2) = 17.9, 
p = 0.0001). Taken separately, only the fluoxetine treatment significantly affected 5-
HT4(e)R mRNA levels (t(17) = −3.28, p = 0.004), but the pCPA treatment had no 
significant effect (t(17) = 0.65, p = 0.52).     
5-HT4(f)R Expression 
In the analysis of 5-HT4(f)R expression, allowing the variance to depend on Age 
or Treatment did not significantly improve the model (L(1) = 3.65, p = 0.06 and L(2) 
= 2.04, p = 0.36, respectively). The model was significantly improved when the 
intercept was allowed to randomly vary across litters (p = 0.04; the estimated standard 
deviation of this variation was 0.066). In the presence of the litter effects, the 
Age×Treatment interaction was not significant (L(2) = 2.27, p = 0.32). Without the 
interaction term, the overall Treatment effect was significant (L(2) = 25.8, p < 
0.0001). Taken separately, only the fluoxetine treatment significantly affected 5-
HT4(f)R mRNA levels (t(17) = −5.31, p = 0.0001), but the pCPA treatment had no 
significant effect (t(17) = 0.102, p = 0.92). 
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Effect of the pCPA Treatment on 5-HT2AR Expression at E15 
The previous analyses showed that the pCPA treatment had no significant effect 
on the three 5-HTRs. However, Figures 3.1 and 3.2 suggest that, at E15, this 
treatment may have increased the mRNA levels of at least some receptors, but this 
effect was undetectable due to insufficient statistical power. To further investigate it, 
we chose the receptor with the strongest apparent change (5-HT2AR) and reanalyzed 
its mRNA levels at E15, considering only the pCPA and control conditions (Figure 
3.1). The mRNA amounts were not log-transformed. If all data points were 
considered independent, the pCPA effect was indeed significant (t(19) = -2.59, p = 
0.018). However, a mixed-effects model detected a strong litter effect (p < 0.0001). 
When this effect was included, the difference between the pCPA and control 
conditions became not significant (L(1) = 2.24, p = 0.13). It was therefore concluded 
that the present data do not provide evidence that inhibition of 5-HT synthesis rapidly 
alters the mRNA levels of the studied receptors.          
Discussion 
We found that inhibition of 5-HT synthesis for 24 hours did not significantly 
affect the mRNA abundance of all studied 5-HTRs in the embryonic telencephalon, 
but that their mRNA levels were significantly reduced by elevation of extracellular 5-
HT for the same length of time. We detected no significant interaction between the 
treatment condition and the developmental time (E15 and E17). The observed mRNA 
responses may represent changes not only in gene transcription, but also in mRNA 
trafficking and degradation (Di Liegro, Schiera, & Di Liegro, 2014; Joseph, Spicer, & 
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Tholanikunnel, 2013; Tholanikunnel et al., 2010). Functionally, a change in mRNA 
abundance does not necessarily indicate a similar change in protein levels 
(Schwanhäusser et al., 2011) or the receptor availability to ligands (Tholanikunnel et 
al., 2010). However, mRNA levels can be measured with the level of specificity and 
quantitative accuracy that is difficult to achieve in protein analyses.  
The lack of significant changes following the inhibition of 5-HT synthesis is 
consistent with the unchanged 5-HT1AR binding in genetic mouse models that lack 
brain serotonergic neurons (Massey et al., 2013) and the unaltered 5-HT1AR, 5-
HT2AR, and 5-HT4R binding in many studied brain regions in young pigs chronically 
treated with pCPA (Ettrup et al., 2011). Likewise, chronic prenatal treatment with 
pCPA has produced no significant changes in the mRNA levels of three out of the 
four 5-HT4R splice variants (5-HT4(a)R, 5-HT4(e)R, 5-HT4(f)R) in the mouse 
telencephalon (Chen et al., 2012). However, chronic prenatal treatment with pCPA 
has strongly decreased 5-HT1AR mRNA in the rat brain (Lauder et al., 2000) and 5-
HT4(b)R mRNA in the mouse telencephalon (Chen & Janušonis, 2014). This suggests 
that unaltered mRNA levels may not indicate insensitivity to 5-HT levels, but may 
rather represent the initial or final points of dynamic processes that could produce 
different results if different developmental and exposure times were used (Janušonis, 
2012b). For example, one hour after a single dose of fluoxetine, 30-40% of membrane 
5-HT1A autoreceptors become internalized in the rat DRN, but three weeks of 
treatment with fluoxetine results in a normal membrane density of 5-HT1AR in these 
neurons (Descarries & Riad, 2012). Likewise, the apparent contradiction between the 
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similar responses of 5-HT4(a)R and 5-HT4(b)R in the acute pCPA treatment and the 
different responses of 5-HT4(a)R and 5-HT4(b)R in the repeated pCPA treatment 
(Chapter 2) might be explained by the different internalization and recycling of these 
splice variants (Mnie-Filali et al., 2010). These differences may become apparent 
only with longer treatment times. Our results suggest that 5-HTR mRNA levels might 
increase if 5-HT synthesis were inhibited for more than 24 hours (Figures 3.1-3.2) 
and perhaps eventually return to their normal levels, if receptor binding signals can be 
used as proxies (Ettrup et al., 2011; Massey et al., 2013).    
The strong decrease in mRNA levels of all three receptors in response to acute 
fluoxetine treatment mirror the results of studies that have used chronic fluoxetine 
exposures (Licht et al., 2009; Shishkina et al., 2012; Vidal et al., 2009). However, this 
apparent simplicity may conceal more complex processes. Chronic fluoxetine 
treatment has decreased 5-HT1AR protein levels in the rat hippocampus, but the 
hippocampal 5-HT1AR protein levels have been significantly increased in rats that had 
been exposed to a mimicked prenatal infection (which reduces 5-HT1AR expression) 
(Lin, Lin, & Wang, 2012). Also, no change in 5-HT2AR mRNA has been found in 
adult mice lacking 5-HTT (Q. Li et al., 2003).  
On a methodological note, this study demonstrates the importance of including 
litter effects in developmental analyses. The baseline mRNA amounts of all 5-HTRs 
significantly varied from litter to litter despite the genetic uniformity of the inbred 
C57BL/6 strain. Disregard for litter effects continues to undermine the validity of 
inferences in many studies, despite the simplicity of mixed-effects analyses and calls 
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to incorporate basic biology into statistical reasoning (Lazic & Essioux, 2013; Lazic, 
2010; Nakagawa & Hauber, 2011).    
The time-dependent biological factors that can affect the transcription and 
translation of 5-HTRs remain poorly understood. A more systematic sampling of 
immediate responses to altered 5-HT levels at different developmental times may 
reveal how the dynamics of 5-HTRs is driven by environmental stimuli. 
 64 
 
 
 
 
 
 
 
 
Chapter 4 
Genetically Altered 5-HT4R Expression Affects the  
Synaptogenesis of the mPFC-DRN Projection 
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Introduction 
In rodents, the mPFC projects directly to the DRN (Hajós et al., 1998; Vertes, 
2004) and dynamically controls behavioral decisions on a fine temporal scale (Challis, 
Beck, & Berton, 2014; Warden et al., 2012). This projection has been implicated in 
the neurobiology of depression, social avoidance, and other related brain states 
(Challis et al., 2014; Lammel, Tye, & Warden, 2014). Strong anatomical and 
functional evidence suggests that the rodent mPFC is homologous to the human 
agranular mPFC (Passingham, Passingham, & Wise, 2012; Preuss, 1995).  
DRN-projecting neurons in the mPFC express several 5-HTRs, the activity of 
which has different effects on DRN targets. Activation of 5-HT1AR in the mPFC 
decreases the firing rate of DRN neurons (Celada et al., 2002; Hajós et al., 1999), 
whereas activation of 5-HT2AR and 5-HT4R has the opposite effect (Bockaert et al., 
2011; Celada et al., 2002; Lucas et al., 2005). The three receptors (5-HT1AR, 5-
HT2AR, 5-HT4R) are coupled to different G-proteins (Gi, Gq, and Gs, respectively) 
and can collectively regulate neuronal excitability (R. Andrade, 2011; Holmes, 2008; 
Janušonis, 2014). Importantly, their expression is upregulated prenatally (Hernandez 
& Janušonis, 2010; Lauder et al., 2000; Waeber et al., 1996), before mPFC projection 
neurons can establish synapses with their brainstem targets (Polleux, Dehay, & 
Kennedy, 1997). Therefore, these receptors are likely to affect the formation and 
stabilization of synapses between mPFC terminals and DRN neurons, and their 
altered expression in perinatal development may result in an abnormal behavioral 
dynamic later in life. To gain a better understanding of these processes, this 
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experiment studied the structure of synaptic contacts between mPFC terminals and 
serotonergic DRN neurons in mice lacking functional 5-HT4Rs. The  mPFC terminals 
in the DRN were visualized by taking advantage of the finding that they express a 
specific vesicular glutamate transporter, vGluT1 (Soiza-Reilly & Commons, 2011a). 
Experimental Procedures  
Animals 
5-HT4R heterozygous mutant (Htr4
+/-
) mice were obtained by breeding 5-HT4R 
receptor homozygous mutant (Htr4
-/-
) mice (strain B6.129P2-Htr4tm1Dgen/J on the 
C57BL/6J background; The Jackson Laboratory) with wild-type (Htr4
+/+
) mice (strain 
C57BL/6J).  These transgenic mice have been used by other researchers (Kobayashi 
et al., 2010). Adult Htr4
+/-
 mice were bred and monitored during pregnancy until the 
birth of offspring. Pups were weaned at postnatal day (PD) 21 and housed with 2-5 
same-sex littermates. All animals were housed on a 12:12 light-dark cycle (lights on 
at 07:00, off at 19:00) with free access to water and food. All experiments were 
approved by the UCSB Institutional Animal Care and Use Committee. 
Immunoelectron Microscopy  
In order to identify how the lack of functional 5-HT4Rs alters the synaptic 
structure of the mPFC-DRN projection in adulthood, we first attempted to visualize 
vGluT1-positive synapses in the DRN by using immunoelectron microscopy. 
Electron microscopy was used because it allows direct observation of synapses. 
Primary antibodies targeting vGluT1 and 5-HT were used to identify mPFC 
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glutamatergic terminals and serotonergic neurons, respectively. Several tissue 
embedding methods were attempted. 
Electron Microscopy with No Immunolabeling. At PD56, offspring were 
terminally anesthetized with a mixture of ketamine (100 mg/kg) and xylazine (10 
mg/kg) and tails were collected and stored at -20°C for genotyping. Anesthetized 
animals were transcardially perfused with 0.9% saline, followed by 100 mL of cold 
4% paraformaldehyde and 1% glutaraldehyde in 0.1M phosphate buffer (PB). The 
brains were dissected from the skull, post-fixed in the same fixative mixture 
overnight, and sectioned on a vibratome at 50 μm thickness. The sections were post-
fixed for 30 minutes in 2% glutaraldehyde in PBS; rinsed 3 times (10 min each) in 
PBS; incubated for 30 minutes in 1% osmium tetroxide in PBS; rinsed 3 times (10 
min each) in PBS; dehydrated in a graded series of ethanol; and transferred into 
propylene oxide. After infiltrating with Durcupan ACM (Fluka, Saint Louis, MO), the 
sections were flat-embedded on glass slides, coverslipped with Liquid Release Agent-
coated coverslips, and polymerized for 48 hours at 55-60°C.  
Thin-sectioning, Contrasting, and Image Acquisition.  Glass knives were cut 
from 38 mm wide glass strips with the LKB 7801B Knifemaker (Vienna, Austria) 
immediately before thin-sectioning. By using the Reichert Ultracut E Microtome 
(Buffalo, NY), embedded sections were semi-thin sectioned at 1 μm thickness, 
stained with a cresyl violet-based stain, and inspected under a light microscope. This 
step was repeated until the desired sectioning depth was reached. The cured sections 
were then ultra-thin sectioned at 90 nm, flattened with chloroform, and collected onto 
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copper grids. After drying, the ultra-thin sections were contrasted with 5% uranyl 
acetate for 20 minutes and Reynold’s lead citrate for 10 minutes, and imaged with the 
JEOL 1230 Transmission Electron Microscope (Tokyo, Japan). Montages were 
assembled manually in high digital magnification, and the editing of images was 
limited to global brightness and contrast. This method was used several times, and 
this section is referred to throughout this chapter. 
Pre-embedding Immunoelectron Microscopy with 3,3’-Diaminobenzidine as 
a Chromogen. In order to develop an immunolabeling protocol for electron 
microscopy, we first used an anti-5-HT antibody. At PD56, offspring were terminally 
anesthetized with a mixture of ketamine (100 mg/kg) and xylazine (10 mg/kg) and 
tails were collected and stored at -20°C for genotyping. Anesthetized animals were 
transcardially perfused with 0.9% saline, followed by 100 mL of cold 4% 
paraformaldehyde and 1% glutaraldehyde in PB. The brains were dissected from the 
skull, post-fixed in the same fixative mixture overnight and sectioned on a vibratome 
at 50 μm thickness. The sections were blocked for 30 minutes in 3% NDS in PBS at 
room temperature; incubated  for 48 hours in 1:1000 goat anti-5-HT IgG 
(ImmunoStar, #200800) with 2% NDS in PBS at 4⁰C; rinsed three times (10 min each) 
in PBS; incubated for 90 minutes in 1:2000 biotinylated donkey anti-goat IgG with 
2% NDS in PBS at room temperature; rinsed 3 times (10 min each) in PBS; incubated 
in the VECTASTAIN Elite ABC solution (1:100, Vector Laboratories) for 1 hr; 
rinsed 3 times (10 min each) in PBS; reacted with 0.05% 3,3’-diaminobenzidine 
tetrahydrochloride hydrate (ISOPAC, Sigma-Aldrich) and 0.01% H2O2 in PBS for 5 
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min; rinsed 3 times (10 min each) in PBS; incubated in 1% osmium tetroxide for 30 
minutes; rinsed 3 times (10 min each) in PBS; dehydrated in a graded series of 
ethanol; and transferred into propylene oxide. Sections were flat-embedded with 
Durcupan ACM and polymerized; the rest of the procedure is described in the section 
―Thin-sectioning, Contrasting, and Image Acquisition.‖  
Pre-embedding Immunoelectron Microscopy with Immunogold. Since the 
previous procedure failed to produce a readily detectable electron-dense signal, we 
next tried an immunogold labeling method. At PD56, offspring were terminally 
anesthetized with a mixture of ketamine (100 mg/kg) and xylazine (10 mg/kg) and 
tails were collected and stored at -20°C for genotyping. Anesthetized animals were 
transcardially perfused with 0.9% saline, followed by 100 mL of cold 4% 
paraformaldehyde and 1% glutaraldehyde in PB. The brains were dissected from the 
skull, post-fixed in the same fixative mixture overnight and sectioned on a vibratome 
at 50 μm thickness. The sections were incubated for 15 minutes in 50 mM glycine in 
PBS for aldehyde inactivation; rinsed three times (10 min each) in PBS; blocked for 
30 minutes in 1% BSA and 2% NDS in PBS at room temperature; incubated  for 48 
hours in 1:1000 goat anti-5-HT IgG (ImmunoStar, #20080) with 2% NDS in PBS at 
4⁰C; rinsed three times (10 min each) in PBS; incubated overnight in 1:100 nanogold-
anti-goat Fab’ (NanoProbes, #2006) with 2% NDS in PBS at 4⁰C; rinsed 3 times (10 
min each) in 2% BSA in PBS; rinsed 2 times (10 min each) in PBS; incubated for 1 
hour in 2% glutaraldehyde; incubated for 15 minutes in 50 mM glycine in PBS for 
aldehyde inactivation; rinsed 2 times (10 min each) in PBS; rinsed 2 times (10 min 
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each) in H2O; enhanced with GoldEnhance EM (NanoProbes, #2113) in the dark; 
rinsed 2 times (10 min each) in H2O; incubated in 1% osmium tetroxide for 30 
minutes; rinsed 3 times (10 min each) in PBS; dehydrated in a graded series of 
ethanol; and transferred into propylene oxide. Sections were flat-embedded with 
Durcupan ACM and polymerized; the rest of the procedure is described in the section 
―Thin-sectioning, Contrasting, and Image Acquisition.‖ 
Post-embedding Immunoelectron Microscopy with Immunogold. The results 
were still unsatisfactory with the previous procedure, so we next attempted a post-
embedding method. The difference between the two methods is in whether 
immunolabeling is performed prior or post embedding. In order to allow 
immunolabeling in tissue after it has been cured in an embedding medium, a water-
soluble resin such as L.R. White (Ted Pella, Redding, CA) is required. At PD56, 
offspring were terminally anesthetized with a mixture of ketamine (100 mg/kg) and 
xylazine (10 mg/kg) and tails were collected and stored at -20°C for genotyping. 
Anesthetized animals were transcardially perfused with 0.9% saline, followed by 100 
mL of cold 1% paraformaldehyde and 1% glutaraldehyde in PBS. The brains were 
removed from the skull and a 1 mm
3
 tissue block was dissected out. The tissue block 
was post-fixed for 1 hour in the same fixative mixture; washed 3 times (10 min each) 
in the same fixative mixture; dehydrated in a graded series of methanol (15%, 30%, 
50%); immersed for 1 hour in uranyl acetate fixative; dehydrated in another graded 
series of methanol (85%, 95%, 100%); infiltrated overnight with 1:1 ratio of 100% 
methanol:L.R. White on a rotator at 4°C; infiltrated for 2 hours with 100% L.R. 
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White on a rotator at 4°C. The last infiltration step was repeated two more times 
before curing the tissue block for 2 days at 52°C. The cured tissue block was trimmed 
with a razor; the rest of the procedure is described in the section ―Thin-sectioning, 
Contrasting, and Image Acquisition.‖  
Immunofluorescent Confocal Microscopy 
Since none of the immunoelectron procedures has produced a reliable electron-
dense signal and preserved ultrastructure in the same preparation, we next used 
multiple-label fluorescent immunohistochemistry with a high-precision confocal 
analysis. Confocal microscopy, unlike epifluorescent microscopy, utilizes improved 
optical methods that can block out the unfocused fluorescent signals above and below 
the optical section and also allows image acquisition in three dimensions with sub-
micrometer accuracy. Once the image has been acquired, advanced image analysis 
software, such as IMARIS (Bitplane), can be used to separate biological signals from 
background noise and distinguish true co-localization from spuriously overlapping 
pixels. This allows unbiased image segmentation and accurate quantitative analyses.  
DNA extraction and genotyping. Genomic DNA (gDNA) was extracted from 
tails using the Genomic DNA Isolation Kit (Lamda Biotech, St. Louis, MO). Briefly, 
1 cm of the tail was digested in a lysis buffer at 56°C overnight; the DNA was 
precipitated with ethanol, dissolved in 150 μL of Tris-EDTA buffer (TE, pH 8.0), and 
stored at -20°C. The altered Htr4 region was amplified by PCR using the primers 5’-
GGGCCAGCTCATTCCTCCCACTCAT-3’, 5’-
AGGGAAAGAGGGCTTTGGGTCATGG-3’, and 5’-
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ATCCAGAGAGGTCCGGACCAGGCAG-3’, as specified by the protocol provided 
by The Jackson Laboratory. These primers yielded two amplification products, a 
mutant variant of 313 bp and a wild-type variant of 400 bp. Each PCR reaction (20 
μL) contained 20 ng gDNA, 0.5 µM of each primer, 0.2 mM dNTP, 0.25U Platinum 
Taq DNA polymerase (Invitrogen), in a PCR buffer containing 10mM Tris-HCl (pH 
9.0 at 25°C), 50mM KCl, 2.5mM MgCl2 , and 0.1% Triton X-100. The amplification 
was performed in a Mastercycler pro thermal cycler (Eppendorf, Hauppauge, NY) 
with the following conditions: initial activation at 95°C for 15 min, 35 cycles of 
amplification (94°C for 30 sec; 60°C for 1 min; 72°C for 1 min), and final extension 
at 72°C for 2 min. The PCR products were run at 120 V on a 1.5% agarose gel in 
Tris-acetate-EDTA buffer (TAE) containing 5% ethidium bromide, and digitally 
imaged with a DigiDoc-It UV transillumination system (UVP, Upland, CA). 
Sample Preparation and Immunofluorescence. At PD56, homozygous and 
heterozygous mice were terminally anesthetized with a mixture of ketamine (100 
mg/kg) and xylazine (10 mg/kg) and their tails were collected and stored at -20°C for 
genotyping. Anesthetized animals were transcardially perfused with 0.9% saline, 
followed by 100 mL of cold 4% paraformaldehyde in PB. The brains were dissected 
from the skull, post-fixed in the same fixative overnight at 4°C, cryoprotected in 30% 
sucrose for two days at 4°C, and used immediately or stored in a cryoprotectant 
containing 30% sucrose, 1% polyvinylpyrrolidone (PVP-40), and 30% ethylene 
glycol in PBS.  
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Brains were sectioned coronally at 40 µm thickness on a freezing microtome and 
sections were kept in PBS for immediate processing or stored at -20°C in the 
cryoprotectant. All rinses and incubations were performed at room temperature. 
Sections were rinsed in PBS (0.1 M, pH 7.2), blocked for 30 minutes in 0.5% bovine 
serum albumin and 0.25% Triton X-100 in PBS, and incubated in a mixture of 
primary antibodies (see Table 4.1) in the same blocking solution overnight. After 
several washes, sections were incubated in a mixture of Alexa Fluor-conjugated 
secondary antibodies (see Table 4.1) in the same blocking solution for 90 minutes. 
After several washes, sections were mounted onto gelatin/chromium subbed glass 
slides, allowed to air dry, and coverslipped with ProLong Gold Antifade mounting 
media with DAPI (Invitrogen).  The specificity of the secondary antibody was tested 
by omitting the primary antibody. The used procedure was based on published reports 
(Calizo et al., 2011; Crawford, Craige, & Beck, 2011; Gibson et al., 2005; Soiza-
Reilly, Anderson, Vaughan, & Commons, 2013). 
Image Acquisition, Segmentation, and Analysis. Sections were preliminarily 
examined and imaged on a Zeiss Axio Imager Z1 system equipped with standard 
epifluorescence filter sets and a color Zeiss AxioCam HRc camera. In selected slides, 
the confocal imaging was performed on a Fluoview 1000 Spectral confocal 
microscope (Olympus) with 10× (0.4 NA, dry) or 60× (1.4 NA, oil) objectives. The 
signals for DAPI, Alexa Fluor 488, Alexa Fluor 568, and Alexa Fluor 633 were 
acquired sequentially, stack by stack, using the laser lines of 405, 488, 546, and 633 
nm, respectively. The laser intensity was adjusted to ensure that the signals were not 
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  Antibody Type Host Manufacturer  Dilution 
anti-5-HT Primary Rabbit ImmunoStar (20080) 1:1000 
anti -GAD67 Primary Mouse Millipore (MAB5406) 1:2000 
anti-VGluT1 Primary Guinea pig Millipore (AB5905) 1:1000 
AF488-conj. anti-rabbit Secondary Donkey Invitrogen (A21206) 1:200 
AF568-conj. anti-mouse Secondary Donkey Invitrogen (A10037) 1:200 
AF633-conj. anti-guinea pig Secondary Donkey Invitrogen (A21105) 1:200 
 
Table 4.1. The antibodies used in immunohistochemistry. Abbreviations: vGluT1, 
vesicular glutamate transporter 1; GAD67, glutamic acid decarboxylase; AF, 
Alexa Fluor. 
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 over-exposed, to reduce non-linear effects in the fluorescent signal. The offset was 
adjusted to slightly underexpose the background, and image resolution was set to 
1024x1024 pixels with a 2x magnification. Starting with the section side closest to the 
coverslip, a z-stack of 12-13 optical sections (0.45 µm in thickness) were obtained for 
each physical section.  
In the first analysis step, we assessed the consistency of the vGluT1 signal in 
each section through the collected z-stack. Each z-stack was cropped to a volume of 
52.8µm x 52.8µm x 1µm. The built-in IMARIS spot function (Bitplane) was used to 
automatically detect vGluT1-positive puncta in each cropped image. The intensity 
threshold, used in the detection, was automatically calculated with the spot function, 
based on a published algorithm (Costes et al., 2004). To assess the reliability of the 
signal, the numbers of vGluT1-puncta in consecutive pairs of optical sections were 
plotted for each physical section (Figure 4.3A). The consistency plot for each 
physical section was inspected blindly to the genotype. Sections with clearly 
inconsistent numbers of vGluT1-puncta were eliminated from the sample set. 
Sections with outlier numbers only at an extreme end of the z-stack were cropped 
appropriately and included in the sample set. An outlier at the beginning or end of a 
stack could be caused by the closeness of the optical section to the surface of the 
physical section (which may contain sectioning microdefects) or by the limited 
penetration of antibodies (if the optical section is deep with respect to the surface).  
The final selected set consisted of 9 Htr4-/- mice, 10 Htr4+/- mice, and 12 Htr4 
+/+ mice. First, the total vGluT1-puncta in each section were automatically detected 
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and counted. This number was normalized by the number of optical sections in the z-
stack. Second, the IMARIS ImarisColoc
1
 (Bitplane) tool was used to build a 
vGluT1/5-HT co-localization channel. Once the colocalization channel has been built, 
the spot function was used again to obtain the number of co-localized puncta, which 
was normalized by the number of optical sections in the z-stack. All images shown in 
the ﬁgures were processed with minor modiﬁcations in global brightness, contrast, 
and gamma adjustments. 
Statistical analysis. Statistical analyses were performed in R 3.0.2 (The R 
Foundation for Statistical Computing) and in IBM SPSS 19 (IBM, Inc.). The data 
were analyzed with one- and two-way ANOVAs. 
                                                        
1 The ImarisColoc is a fully automatic tool that utilizes a sophisticated colocalization threshold 
selection algorithm proposed by Costes et al. (2004). This tool allows more accurate threshold 
selections and minimizes the false-positive error, producing a result that is both robust and 
reproducible (Dunn, Kamocka, & McDonald, 2011). This method uses Pearson’s correlation 
coefficient (PCC) to objectively identify the background threshold, then Mander’s correlation 
coefficients are calculated as the fraction of overlapping pixels (colocalization) above the background 
threshold set by PCC.  
 77 
 
Results 
Immunoelectron Microscopy 
When the Durcupan resin was used to embed the tissue and no immunolabelling 
was used, well-preserved ultrastructure was observed in the DRN. As shown in 
Figure 4.1A, synapses, myelinated axons, and synaptic vesicles were clearly visible. 
The immunolabeling with DAB greatly reduced the quality of the ultrastructure, and 
unspecific electron-dense areas were observed (see Figure 4.1B). No specific signal 
was obtained with the Nanogold immunolabeling, which resulted in uniformly 
distributed electron-dense particles of the correct size (see Figure 4.1C). Lastly, when 
the water-soluble embedding resin (L.R.White) was used, , the ultrastructure was not 
preserved (see Figure 4.1D). Because of these technical challenges, we took a 
different approach, which is described next. 
Immunofluorescent Confocal Microscopy 
We investigated the density of contacts between mPFC afferents (positive for 
vGluT1) and serotonergic neurons in the DRN of Htr4
-/-
, Htr4
+/-
, and Htr4
+/+
 mice 
(Figure 4.2A). Consistent with previous reports (Crawford et al., 2011; Soiza-Reilly 
& Commons, 2011a), vGluT1-positive puncta were especially dense in the 
ventromedial DRN (vmDRN) (Figure 4.2B). Therefore, we focused on this DRN 
subdivision, in which we automatically detected and counted puncta that were 
immunoreactive for vGluT1 only, or for both vGluT1 and 5-HT (Figure 4.2C).  
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Figure 4.1. (A) An electron micrograph of the DRN. Shown are synapses (arrows), 
myelinated axons (circles) and vesicles (asterisks). The ultrastructure is well 
preserved. (B) An electron micrograph of the DRN, labeled using a pre-embedding 
staining protocol with an anti- 5-HT antibody and DAB as a chromogen. The 
ultrastructure is reasonably well preserved, but non-specific electron-dense areas 
obscure the immunosignal. (C) An electron micrograph of the DRN, labeled using a 
pre-embedding staining protocol with an anti-5-HT antibody and Nanogold. The 
ultrastructure is less well preserved and Nanogold particles are uniformly distributed. 
(D) An electron micrograph of the DRN, embedded in  L.R. White resin. The 
ultrastructure is not preserved. Scale bars = 2 μm. 
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Figure 4.2. (A) A schematic representation of the direct projection from the mPFC to 
the DRN. The study investigated contacts (yellow) between glutamatergic mPFC 
afferents and serotonergic neurons using vGluT1 and 5-HT as immunomarkers. (B) A 
typical section through the DRN showing the distribution of 5-HT-positive neurons 
(green), vGluT1-positive puncta (red), and cell nuclei (blue). Abbreviations: Aq, 
cerebral aqueduct; dm, dorsomedial DRN; mlf, medial longitudinal fasciculus; vm, 
ventromedial DRN; lDRN, lateral DRN. Scale bar = 100 μm. (C) Automatic detection 
of 3D-colocalization between vGluT1 and 5-HT (pseudo-colored red) 
immunoreactive profiles. Scale bar = 10 μm. 
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Immunosignals often vary in intensity at different distances from the section 
surface due to sectioning microartifacts, limited antibody penetration, depth-
dependent optical properties, and other factors. In order to avoid this artifact in our 
high-resolution analyses, we first examined the genotype-blind counts of vGluT1-
positive puncta through the entire z-stacks of all individual mice and eliminated the 
mice in which these counts were clearly inconsistent (Figure 4.3A). The final set 
included 9 Htr4
-/-
 mice, 10 Htr4
+/-
 mice, and 12 Htr4
+/+
 mice. In the wild-type 
(Htr4
+/+
) mice, the mean counts of vGluT1-positive puncta and vGluT1/5-HT-
positive puncta per optical section were 54.7 ± 3.5 and 19.1 ± 3.3, respectively. The 
proportion of the vGluT1-positive puncta colocalized with 5-HT with respect to all 
vGluT1-positive puncta was therefore around 35%, which is consistent with an array 
tomography analysis of wild-type C57BL/6 mice (Soiza-Reilly & Commons, 2011b). 
A two-way ANOVA showed no significant effects of sex or genotype on the 
counts of vGluT1-positive puncta (F(1, 25) = 0.010, p = 0.92 and F(2, 25) = 0.443, p 
= 0.65, respectively) (Figure 4.3B). A two-way ANOVA revealed a significant effect 
of genotype on the counts of vGluT1-positive puncta colocalized with 5-HT (F(2, 25) 
= 5.727, p = 0.009) (Figure 4.3C), but the effects of sex and the genotype-sex 
interaction were not significant (F(1, 25) = 0.843, p = 0.37 and F(2, 25) = 1.292, p = 
0.29, respectively). A post-hoc analysis confirmed that the heterozygous mice had 
significantly more vGluT1/5-HT-positive puncta than the two homozygous groups (p 
< 0.03). 
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Figure 4.3. (A) The reliability analysis of automatically-depicted vGluT1-positive 
puncta in serial optical sections through the same physical section. Cases were 
included in the analysis only if the counts of puncta were relatively stable across the 
pairs of adjacent optical sections (mouse #30) or if the counts became relatively 
stable after the elimination of a small number of optical sections at an extreme end of 
the z-stack (mouse #36; the eliminated points are circled). Cases with unstable counts 
(mouse #35) or with outlier counts in the middle of the z-stack were not included in 
the analysis. (B) vGluT1-positive puncta in the vmDRN of Htr4
-/-
, Htr4
+/-
, and Htr4
+/+
 
mice. The genotypes were not significantly different (one-way ANOVA: F(2,28) = 
0.165, p = 0.85). (C) Puncta with colocalized vGluT1 and 5-HT immunoreactivity in 
the vmDRN of Htr4
-/-
, Htr4
+/-
, and Htr4
+/+
 mice. The heterozygous mice had 
significantly more contacts between vGluT1-positive terminals and 5-HT-positive 
cells bodies and dendrites (one-way ANOVA: F(2, 28) = 7.542, p = 0.002; Tukey’s 
HSD post-hoc tests for +/- vs. -/- and +/- vs. +/+: *p < 0.03). Error bars = SEM (B 
and C). 
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Discussion 
We found that the absence of functional 5-HT4Rs had no significant effect on the 
overall density of mPFC terminals in the DRN, but that the density of mPFC 
terminals colocalized with serotonergic neurons was significantly increased in 
heterozygous mice. This increase was unlikely to be due to a larger proportion of 
serotonergic neurons in the DRN because the densities of 5-HT-positive neurons are 
not significantly different in the DRN of 5-HT4R-knockout and wild-type mice 
(Conductier et al., 2006). Also, it is unlikely that the observed change was caused by 
altered 5-HT4R signaling in the DRN itself because its expression of 5-HT4R is very 
low (Lucas et al., 2005; Suwa et al., 2014).   
Since many mPFC afferents terminate on GABAergic neurons in the DRN 
(Calizo et al., 2011; Fu et al., 2010; Jankowski & Sesack, 2004), the unchanged 
overall density of mPFC terminals may reflect a lower density of mPFC-GABAergic 
synapses in 5-HT4R heterozygous mice. These synapses appear to play an important 
role in real-time behavioral control (Challis et al., 2013, 2014). In addition to the 
presented data, we attempted to directly quantify the colocalization between vGluT1-
positive puncta and GAD67-positive profiles in the DRN with an anti-GAD67 
antibody that has been used in other studies (Fu et al., 2010; Shikanai et al., 2012), 
but could not obtain a sufficiently reliable signal for automatic colocalization 
detection (Costes et al., 2004). However, a large proportion of GABAergic axons in 
the DRN form synaptic ―triads‖ with vGluT1-positive terminals and the same 
postsynaptic target (Soiza-Reilly et al., 2013), which suggests that many mPFC-
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GABAergic synapses eventually modulate the activity of the same serotonergic 
neurons that receive direct mPFC projections. 
The finding that the density of contacts between mPFC terminals and 
serotonergic neurons was affected in heterozygous but not homozygous mice was 
unexpected, but it allows interesting interpretations. The brain is a complex system 
and it is likely to show a non-linear behavior when pushed far away from its 
equilibrium (such as when a functional gene is missing). A stronger perturbation can 
result in a smaller effect due to simple dynamical properties of the system (Janušonis, 
2012a), or it may recruit major compensatory mechanisms that remain dormant if the 
gene is functional (even if its activity is lower than normal). This has been observed 
in other studies; for example, a null-mutation of the parkin gene alters the synaptic 
activity in the hippocampus of heterozygous but not homozygous knockout mice 
(Hanson, Orr, & Madison, 2010). These observations may be particularly relevant to 
human studies, where the expression of serotonin receptors is more likely to be 
moderately affected by environmental factors (including pharmacological agents) 
than completely abolished by genetic mutations.   
While the electron microscopy analysis did not produce quantifiable results, 
excellent brain ultrastructure was obtained in unlabeled samples. Given that 
functional changes in structure have been observed in the DRN of 5-HT4R deficient 
mice (Conductier et al., 2006), this technique may be useful for the quantification of 
morphological changes that do not require immuno-labeling, such as the ratio 
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between excitatory and inhibitory synapses, or the patterns of myelination. This 
analysis also showed that further refinement is needed in the selection of regions of 
interest, even if they are located in the same DRN subdivision (e.g., the ventromedial 
DRN), because the DRN ultrastructure is remarkably heterogeneous (Marinelli et al., 
2004). 
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Chapter 5 
General Discussion 
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The obtained results demonstrate that chronic and acute developmental 5-HT 
perturbations alter 5-HTR mRNA expression in the embryonic telencephalon, and 
that altered 5-HTR expression in development affects the formation of synapses 
between mPFC terminals and serotonergic neurons in the DRN. A combination of 
pharmacology, mRNA quantification, genetic models, immunofluorescence, and 
confocal microscopy showed that an optimal 5-HT environment is required for the 
normal up- and down-regulation of 5-HTRs in forebrain development and for the 
normal development of the prefrontal control of the 5-HT system. Our findings 
suggest that common maternal factors that can affect the 5-HT system, such as 
prenatal stress or SSRIs, can lead to abnormalities in the wiring of the fetal brain. 
This implies that such factors may compromise the mPFC control of neurotransmitter 
systems in adolescence and adulthood. Because the mPFC is implicated in most, if 
not all, cognitive deficits in psychiatric disorders, it is of great clinical importance to 
understand which developmental perturbations can induce long-lasting 5-HTR 
changes and may result in functional changes in prefrontal efferent projections.  
The Role of 5-HT: Temporal Sensitivity in Development 
It has long been known that 5-HT is involved in various developmental 
processes. In particular, 5-HT plays an important role in fetal brain development, an 
especially complex and dynamic process. The homeostatic regulatory system, which 
tightly controls the mature CNS, is not yet completely functional in the embryonic or 
fetal brain. Because of the highly dynamic nature of development, coupled with the 
lack of fully-developed regulatory mechanisms, the brain is susceptible to various 
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environmental or pharmacological perturbations. Since such perturbations are not 
uncommon in modern society, their pros and cons have to be well understood, 
especially because pregnant women can make conscious decisions about some of 
them.  
Specific events must occur at specific times and in a specific order for a 
biological system to develop and function properly. This is also true regarding the 
maturation and integration of the brain 5-HT system during development. All CNS 5-
HT is synthesized in the RN, and, in the mouse, serotonergic axons do not reach the 
developing telencephalon until approximately E15 (Aitken & Törk, 1988; Lidov et al., 
1980). However, 5-HTR expression can be detected in the forebrain many days 
before serotonergic axons reach this part of the brain. A series of elegant studies 
(Bonnin & Levitt, 2011, 2012; Bonnin et al., 2011) have shown that, in mice, the 
maternal placenta supplies 5-HT to the embryonic forebrain prior to E15, and that 
only around E17 does the endogenous RN supply become the primary 5-HT source. 
Combined with the findings of Hernandez and Janušonis (Hernandez & Janušonis, 
2010), which showed rapid upregulation of some 5-HT4R splice variants at E15 and 
E17, it appears that 5-HTR expression should be highly susceptible to environmental 
factors at specific developmental times. The experiments in this thesis showed that 
this susceptibility is not only temporally specific, but that it is also 5-HTR specific. A 
significant decrease in mRNA levels of the 5-HT4(b)R splice variant at E17 was 
observed following PS and 5-HT depletion from E14 to E16, while the other 5-HTR 
splice variants showed no significant changes in mRNA levels. These findings 
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contribute to the growing body of literature on embryonic 5-HTand provide further 
evidence that common prenatal perturbations can affect 5-HTRs in the developing 
forebrain in a time-sensitive manner. The clinical relevance of these effects requires 
more translational research.  
Susceptibility to Prenatal Perturbation 
It has been shown that various types of maternal adversity, including PS, can 
impact the 5-HT system of the mother and can consequently affect the development 
of neural circuits in the fetal brain. Approximately 50% of women report an increase 
in stress-related symptoms during pregnancy (Evans, Heron, Francomb, Oke, & 
Golding, 2001; Faisal-Cury & Rossi Menezes, 2007; Heron, O’Connor, Evans, 
Golding, & Glover, 2004; Rubertsson, Wickberg, Gustavsson, & Rådestad, 2005). 
Increased stress levels during pregnancy may have short-term and long-term 
consequences in the development of the fetal brain. In general, common negative 
factors during pregnancy include pregnancy anxiety, catastrophic events, major life 
events, chronic stress, and depressive symptoms (Dunkel Schetter & Tanner, 2012). It 
has been shown in human studies that PS is associated with major depressive disorder, 
generalized anxiety disorder, and schizophrenia in the offspring later in life 
(Markham & Koenig, 2011). Using animal models, similar findings have been 
reported. Animals that have experienced PS often show anxiety- and depression-like 
behaviors, such as decreased time spent in the open-field test and in the open arms of 
the plus-maze test, as well as increased immobility in the forced-swim test (Bogoch, 
Biala, Linial, & Weinstock, 2007; Morley-Fletcher et al., 2003; Neumann, Krömer, & 
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Bosch, 2005; Ordyan & Pivina, 2004; Rayen, van den Hove, Prickaerts, Steinbusch, 
& Pawluski, 2011; Zagron & Weinstock, 2006). Also, many effects of PS exposure 
on the adolescent and adult 5-HT systems have been demonstrated. PS has been 
associated with altered 5-HT levels and synthesis, 5-HTR expression and binding, 
and changes in behavioral outcomes following 5-HTR activation (Hayashi et al., 2010; 
D. A. V. Peters, 1986a, 1986b, 1990). 
 An increasing number of women are prescribed SSRI medications (S. E. 
Andrade et al., 2008) and SSRIs are often used to treat depression during pregnancy 
and the postpartum period. Many SSRIs readily cross the placental barrier and affect 
the fetus prenatally; also, SSRIs have been reported to affect infants postnatally due 
to their presence in breast milk (Gentile, 2005). Even though the effects of SSRI 
exposure to developing embryos are not yet fully understood, increasing clinical data 
associate SSRI exposure with abnormalities such as premature birth and low birth 
weight (Oberlander, Warburton, Misri, Aghajanian, & Hertzman, 2006; Wisner et al., 
2009). Many studies have shown that prenatal and early postnatal exposure to SSRIs 
are linked to depression- and anxiety-like behaviors in adolescent and adult offspring 
(Ansorge, Morelli, & Gingrich, 2008; Hansen, Sánchez, & Meier, 1997; Karpova, 
Lindholm, Pruunsild, Timmusk, & Castrén, 2009; Rayen et al., 2011; Smit-Rigter et 
al., 2012), as also observed with PS exposure. Paradoxically, it has been shown in 
animal studies that early postnatal SSRI exposure can reverse the neurobiological and 
behavioral effects of PS (Nagano et al., 2012; Rayen et al., 2011). Early studies have 
established the role of 5-HT in stress-related disorders, while recent studies have 
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identified some forebrain regions, including the mPFC, to be involved in 5-HT-
mediated stress responses. It has been shown that acute stress increases glutamate in 
several regions of the forebrain, including the PFC (Bagley & Moghaddam, 1997; 
Lowy, Wittenberg, & Yamamoto, 1995; Reznikov et al., 2007), while chronic 
treatment with SSRIs abolishes the stress-induced upregulation of glutamate release 
(Bonanno et al., 2005; Michael-Titus, Bains, Jeetle, & Whelpton, 2000; Tokarski, 
Bobula, Wabno, & Hess, 2008).  
Even though a large body of research has examined the effects of PS and SSRI 
on offspring, the effects of these prenatal exposures on the developing 5-HT system 
remain poorly understood. The present thesis reports some interesting and unexpected 
results, the clinical relevance of which warrants further investigation. 
A paradoxical result was obtained when PS, which increases 5-HT levels in the 
embryonic brain (D. A. V. Peters, 1990), and pCPA, which decreases 5-HT levels in 
the embryonic brain, led to a decrease in mRNA levels of the 5-HT4(b)R splice variant. 
A similar study has found that both an increase and a decrease in prenatal 5-HT levels 
results in lower 5-HT1AR mRNA levels in the embryonic rat brain (Lauder et al., 
2000). Surprisingly, the acute 5-HT depletion with a TPH inhibitor had no effect on 
the mRNA levels of 5-HT1AR, 5-HT2AR, and all 5-HT4R splice variants, while the 
mRNA levels of all examined 5-HTRs decreased in response to the acute SSRI 
treatment. This suggests that a decrease in 5-HT levels may produce smaller 
deviations from the normal developmental 5-HTR expression, compared to an 
increase in 5-HT levels, for which the response appears to be more drastic. Perhaps 
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this is because a low-5-HT state more closely approximates early developmental 
conditions when the 5-HT concentration may still be low. Many perplexing and 
conflicting findings have been reported by other researchers, possibly due to 
differences in the experimental parameters, such as treatment length and dosage. 
Because the developing system changes dynamically, acute, pulse-like exposures at 
different developmental times are essential in characterizing and understanding 
receptor susceptibility to prenatal perturbations.   
5-HT and the mPFC-DRN Projection 
Upon confirming that prenatal perturbations can affect the mRNA expression of 
some 5-HTRs, we next studied whether the normal 5-HTR expression is necessary for 
the development of neural circuits. Specifically, we investigated whether 5-HT4Rs are 
required for the normal formation of synapses between mPFC terminals and 
serotonergic neurons in the DRN. In addition to being susceptible to prenatal 
perturbations, 5-HT4R is expressed in DRN-projecting mPFC pyramidal cells. The 
mPFC is one of the few brain areas that send reciprocal projections to the DRN and 
function as 5-HT synthesis/release regulators. Because the PFC is the executive 
headquarters of the CNS and receives information directly and indirectly from all 
cognitive areas, it can integrate this information to decide whether more or less 5-HT 
has to be released from the DRN (Sharp, 2009). The mPFC then sends a signal to the 
DRN via its glutamatergic projections to modulate the activity of serotonergic 
neurons.  
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Local application of a 5-HT1AR agonist in the mPFC has been shown to reduce 
the firing rate of serotonergic neurons in the DRN (Hajós et al., 1999). A potential 
mechanism for this reduction is the inhibition of mPFC GABA interneurons and the 
consequent disinhibition of mPFC glutamatergic projections to DRN GABA 
interneurons, which in turn inhibit DRN serotonergic neurons (Aznar, Qian, Shah, 
Rahbek, & Knudsen, 2003; Santana, Bortolozzi, Serrats, Mengod, & Artigas, 2004). 
A systemic injection of a 5-HT2AR agonist, DOI, has been shown to induce an 
increase in c-fos expression in DRN GABA neurons (Boothman & Sharp, 2005), 
which in turn inhibit the firing of serotonergic neurons in the DRN. Lastly, 
overexpression of 5-HT4R in the mPFC with a viral transfection method has been 
shown to increase the firing rate of serotonergic neurons in the DRN (Lucas et al., 
2005), likely by stimulating the mPFC glutamatergic afferents that terminate directly 
on serotonergic neurons. The vesicular glutamate transporter (vGluT) is present in all 
glutamatergic terminals. Fremeau et al.(2001) have reported that vGluT1 mRNA is 
mainly expressed in telencephalic areas, including the mPFC, while vGluT2 mRNA 
is expressed mainly in subcortical areas. This information was used to quantify the 
synaptic structure of the mPFC-DRN projection.  
We found that the number of synapses between mPFC terminals and 
serotonergic DRN neurons was markedly increased in Htr4
+/-
 mice, showing an 
abnormal connectivity between the mPFC and the DRN. This confirms that 
developmental perturbations in 5-HTR expression can permanently alter the 
prefrontal control of brain 5-HT. Interestingly, no changes were observed in the 
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number of mPFC-DRN synapses in Htr4
-/-
 mice, indicating that the complete absence 
of a 5-HTR may trigger major compensatory processes. This is supported by the 
results of a study that has found that heterozygous, but not homozygous, parkin-
deficient mice exhibit functional synaptic impairments in the hippocampus (Hanson 
et al., 2010).  
Potential Implications for 5-HT Research 
In conclusion, our results indicate that acute and chronic prenatal 5-HT 
perturbations can affect 5-HTR mRNA expression in the embryonic telencephalon, 
and that constitutively low 5-HT4R expression (due to a genetic deletion on one 
chromosome) may lead to changes in the mPFC-DRN projection. To achieve a better 
clinical interpretation of these results, it is important to understand whether changes 
in 5-HTR expression that are not related to genetic mutations can also persist into 
adolescence and adulthood.  5-HT1AR has long been a target for research 
investigating the neurobiological basis of depression. Studies have suggested that the 
SSRI therapeutic lag corresponds to the time required for the DRN 5-HT1A 
autoreceptor to desensitize (Piñeyro & Blier, 1999). 5-HT1ARs regulate 5-HT release 
by inhibiting serotonergic neurons in the DRN; therefore, an increase in synaptic 
SSRI would lead to increased inhibition by 5-HT1ARs. It has therefore been proposed 
that inhibiting DRN 5-HT1A autoreceptors with a 5-HT1AR antagonist could induce a 
more rapid onset of SSRI effects (Francesc Artigas, Romero, De Montigny, & Blier, 
1996). The research of 5-HT2AR in the PFC has focused on its role in modulating 
other neurotransmitters, such as dopamine and glutamate release; specifically, 
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antagonism at 5-HT2ARs has been shown to inhibit dopamine release in the PFC 
(Pehek, Nocjar, Roth, Byrd, & Mabrouk, 2006). Additionally, selective 5-HT2AR 
antagonists have been shown to have antidepressant properties in rodents (Albinsson, 
Björk, Svartengren, Klint, & Andersson, 1994; J. G. Patel, Bartoszyk, Edwards, & 
Ashby, 2004), and thus have also been proposed as an adjunct treatment to SSRIs 
(Marek, Carpenter, McDougle, & Price, 2003; Marek, Martin-Ruiz, Abo, & Artigas, 
2005). A 5-HT4R partial agonist, RS67333, has been demonstrated to have rapid-
onset antidepressant-like effects in rodents. A 3-day exposure to 5-HT4R agonists has 
been shown to effectively desensitize 5-HT1A autoreceptors and decrease depression-
like behaviors, such as reduced immobility in the forced swimming test (Lucas et al., 
2007).  
 To achieve better clinical relevance, it is important to know which prenatal 
alterations of brain development persist into adolescence and adulthood.  
Understanding the regulatory processes and relationships among the various 
components of the 5-HT system, especially with regard to brain development, is 
crucial in and of itself. It will provide us with a stronger grasp on one of the most 
abundant neurotransmitters, including its role in shaping neural communication 
networks. 
General Limitations and Future Directions 
Measurement of Receptor Expression with qRT-PCR.  
For many 5-HTRs, including 5-HT4R, the specificity of antibodies remains 
questionable or poorly characterized, which greatly limits the utility of 
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immunohistochemistry, especially in quantitative applications. Because of these 
limitations, in this thesis the mRNA levels of 5-HTRs were used to assess receptor 
expression levels. The mRNA levels were measured with qRT-PCR, currently the 
most accurate and specific quantitative technique. However, measures of receptor 
protein levels would provide more direct information needed for functional 
interpretations. It has been reported that mRNA transcription levels predict 
approximately 40% of protein production, and that translation efficiency more 
accurately reflects protein expression (Schwanhäusser et al., 2011). A separate study 
has found that changes in protein levels are often not accompanied by changes in the 
corresponding mRNA levels (R. Lu et al., 2009). These studies show that 
translational and post-translational processes are highly important, potentially more 
so than transcription itself. Since finding changes in mRNA expression cannot be 
immediately generalized to changes in receptor protein expression, findings reported 
in this thesis should be interpreted with caution.  
Spatial Precision of Sampling is Lacking in the qRT-PCR studies.  
Even though the qPCR method provided accurate quantitative information about 
mRNA levels, the spatial anatomical information was limited. Because the entire 
telencephalon (both hemispheres for E13-E15, one hemisphere for E16-E18) was 
used to extract mRNA, potentially important changes in telencephalic regions may 
not have been detected or may have been obscured by high receptor expression in 
adjacent regions. In the future, punching smaller telencephalic areas may be used for 
more targeted expression analyses. This way, more detailed information can be 
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obtained from the quantification data, making findings more amenable to functional 
interpretations. Also, techniques with a better spatial resolution, such as in situ 
hybridization, could be used in conjunction with qRT-PCR to measure mRNA levels 
in small anatomical regions. Recent advancements in commercially available 
fluorescent in situ hybridization (FISH) allow for the precise identification of 
multiple gene expression patterns within a single sample, in addition to better spatial 
localization. 
Maternal Restraint Stress as Prenatal Stress (PS).  
In the repeated perturbation study in Chapter 2, PS was used instead of 
pharmaceuticals to increase embryonic 5-HT levels, because PS commonly occurs in 
pregnant women. However, PS can lead to a wide range of neurological responses, 
including the activation of the hypothalamic-pituitary-adrenal axis. Also, the very 
different forms (restraint stress, social stress, food/drink deprivation, swim stress, 
reversal of the light-dark cycle, tail pinch, bright light stress, motion stress, 
dexamethasone injection, or some combination of the above) and lengths of 
laboratory stress treatments have possibly contributed to conflicting results in PS 
research. The maternal restraint stress regime (1 hour/day) used here was relatively 
mild in comparison to other PS studies. Exposure to short-lasting, mild, and long-
lasting (severe) PS has led to opposite outcomes in studies on neonatal neurogenesis 
and differentiation of hippocampal neurons (Fujioka, Fujioka, Ishida, Maekawa, & 
Nakamura, 2006). Also, it is possible that animals can become desensitized to the 
same stress regime after some time. Restraint stress also does not translate well to 
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dynamic real-world stressors, such as physical and emotional stressors, that pregnant 
women encounter on a daily basis. Preferably, a combination of stressors should be 
used in PS experiments in order to minimize stress desensitization and mimic real-
world stressful conditions.  
Choice of Pharmacological Agents for 5-HT Perturbations.  
An important consideration for future research is determining which 
pharmaceutical agents are best suited for 5-HT manipulation. One potential issue with 
acute SSRI and pCPA exposures is the time-course of the effects. SSRIs increase 5-
HT neurotransmission by blocking reuptake transporters, thus rapidly increasing 
synaptic 5-HT levels. In contrast, pCPA decreases 5-HT neurotransmission by 
inhibiting 5-HT synthesis, and thus decreases 5-HT levels gradually, as the 5-HT 
supply becomes depleted. Due to this difference, an alternative 5-HT-depleting agent 
or a 5-HTR antagonist should be used for a better comparison. Using high 
performance liquid chromatography (HPLC) to measure regional 5-HT and 5-HIAA 
contents may provide important information about the effectiveness of these 
treatments.  
Lack of Functional Data in the Study of the mPFC-DRN Projection in 5-
HT4R -deficient Mice.  
To further elucidate the effects of altered 5-HT4R expression due to the mutation 
in the 5-HT4Rgene, methods that directly measure regional neurotransmitter levels, 
such as microdialysis with HPLC, could be used. Measuring the glutamate and 5-HT 
levels in the mPFC and DRN of 5-HT4R-transgenic mice would provide important 
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data about the role of 5-HT4R in the prefrontal control of 5-HT signaling. It would 
also be informative to utilize regionally specific gene-knockdown methods over a 
short period of time. In this approach, the activation of compensatory mechanisms 
would be less significant, allowing for more precise analyses of the effects of 
decreased 5-HT4R expression during critical developmental times.  
Another important question regarding the findings in Chapter 4 is the 
developmental time at which 5-HT4Rs are first expressed in the mPFC. 5-HT4Rs are 
expressed on pyramidal mPFC cells in the adult mouse brain, but it remains unclear 
whether 5-HT4Rs are expressed on cortical pyramidal cells prenatally. In order to 
achieve this, high-precision methods, such as single-cell PCR, could be utilized to 
extract information about 5-HT4R expression in specific cortical cells. Lastly, 
functional data can be obtained by using electrophysiological or optogenetic methods 
to determine how the altered synaptic connectivity in the DRN of 5-HT4R 
heterozygous mice has affected the mPFC regulation of DRN neuronal activity. 
Future Directions for the Study of the 5-HT4R System.  
Future research will benefit from increasingly sophisticated transgenic models 
that target specific components of the 5-HT system. Recently, a 5-HT4R BAC-
transgenic mouse model has been produced (Tg(Htr4-EGFP)AU103Gsat/Mmmh, 
www.mmrrc.org). In this model, the enhanced green fluorescent protein (EGFP) 
reporter gene is inserted immediately upstream of the coding sequence of the 5-HT4R 
gene, which allows the visualization of 5-HT4R directly with conventional 
epifluorescent and confocal microscopy. This model can be used to profile the 
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developmental trajectory of 5-HT4R, as well as its susceptibility to prenatal 
perturbations, and therefore may complement the findings reported in this thesis. 
Neurons expressing 5-HT4Rs in 5-HT4R-EGFP mice can be cultured to dynamically 
track receptor interactions with other proteins by using live imaging.  
Since 5-HT4R splice variants differ in their functional properties, (Claeysen et al., 
2001; Mnie-Filali et al., 2010), including their different responses to PS and 5-HT 
depletion (reported in this thesis), the development of 5-HT4R splice variant-specific 
ligands is critical in further research. A 5-HT4R partial agonist has been proposed as a 
rapid-onset antidepressant (Lucas et al., 2007), but the expression of these receptors 
in the gastrointestinal system cause side effects that may outweigh the antidepressant 
effect. Since the mouse 5-HT4(e)R and 5-HT4(f)R splice variants appear to be brain-
specific, development of 5-HT4R splice-variant specific ligands may lead to 
breakthroughs in the development of new treatment options for depression and other 
mental disorders.  
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